Compounds > fibrinogen
Page last updated: 2024-08-26

fibrinogen and Diabetes Mellitus, Type 2

fibrinogen has been researched along with Diabetes Mellitus, Type 2 in 350 studies

Research

Studies (350)

TimeframeStudies, this research(%)All Research%
pre-199019 (5.43)18.7374
1990's71 (20.29)18.2507
2000's142 (40.57)29.6817
2010's87 (24.86)24.3611
2020's31 (8.86)2.80

Authors

AuthorsStudies
Ahmad, S; Akhter, F; Alatar, AA; Faisal, M; Hu, B; Rehman, S; Song, J1
Abidi, M; Faiz Faizy, A; Perween, S1
Aziz, IA; Basit, A; Fawwad, A; Nangrejo, R; Perveen, K; Siddiqui, IA; Waris, N1
Gao, R; Jia, S; Li, T; Song, Y; Tang, X; Wang, P; Xu, B; Xu, J; Yang, Y; Yuan, D; Yuan, J; Zeng, G; Zhang, C; Zhao, X; Zhu, P1
Akter, QS; Haque, S; Karim, F; Khanom, A; Rashid, MS1
L, H; M, RK1
Antonova, N; Paskova, V; Velcheva, I1
Fei, X; Han, F; Pan, L; Wo, M; Wu, Y; Xu, C; Ye, Y; Zhu, F1
Ardeshirrouhanifard, S; Dai, H; Li, J; Li, M; Song, Y; Zhang, X1
Guo, B; Liu, D; Song, M; Wang, B; Wang, W; Wang, Y1
Flick, MJ; Hur, WS; Juang, LJ; Kastrup, CJ; King, KC; Leung, J; Luyendyk, JP; Nguyen, YV; Patel, YN; Wei, Z; Wolberg, AS; Yang, Y1
Kell, DB; Kruger, A; Laubscher, GJ; Pretorius, E; Turner, S; Venter, C; Vlok, M1
Erasmus, RT; Hill, J; Kengne, AP; Lopes, T; Mchiza, ZJ; Peer, N; Zemlin, AE1
Cai, Q; Fu, Z; Huang, H; Zhang, J; Zhuang, Y1
Ao, P; Gu, WL; Huang, XJ; Jiang, Y; Li, ZH; Wei, L; Zhang, DF; Zhang, SQ; Zhang, XY; Zhao, X; Zhu, XB1
Dharmalingam, K; Jeya Maheshwari, J; Kannan, NB; Kohli, P; Parida, H; Ramasamy, K; Sen, S; Udaya, P1
Kong, Y; Li, X; Lu, C; Wu, Q1
Ao, P; Cao, Q; Gu, W; Huang, X; Jiang, Y; Li, Z; Sun, Y; Wang, S; Wei, L; Ye, Z; Zhang, D; Zhang, X; Zhu, X1
Cai, Y; Shang, J; Simmons, D; Wang, Z; Yu, D; Zhao, B; Zhao, Z1
Cao, P; Chan, L; Chan, P; Chang, Z; Chao, Y; Chen, Z; Deng, B; Lyu, Q; Pan, Y; Que, R; Tan, EK; Wang, Q; Wang, T; Wang, Y; Xu, L; Yang, W; Yenari, MA; Yuan, F; Zhu, S1
Dao, M; Deng, Y; Karniadakis, GE; Li, X; Mantzoros, CS; Papageorgiou, DP; Perakakis, N1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J1
Deveci, B; Gazi, E1
Carr, AL; Forster, R; Grecian, SM; McLachlan, S; Price, JF; Sluiman, AJ; Strachan, MWJ1
Abunada, T; C, GPD; D, TK; Ethiraj, S; Okashah, S; Rajan, B; S, UK; V, AP; Younes, S; Zayed, H1
Bryk, AH; Undas, A; Wiśniewski, JR; Zettl, K1
Chen, JG; Peng, TW; Xu, GQ; Zhang, HB; Zhang, YH; Zhao, SC; Zuo, Y1
Ahmad, S; Alatar, AA; Alouffi, S; Faisal, M; Qahtan, AA; Rehman, S1
Barquero-Perez, O; Garcia-Carretero, R; Vigil-Medina, L1
Fei, X; Huang, Q; Ma, J; Song, Y; Wo, M; Wu, H1
Andreozzi, F; Fiorentino, TV; Mannino, GC; Marini, MA; Perticone, F; Perticone, M; Sciacqua, A; Sesti, G1
Hu, L; Liu, R; Wang, R; Xu, D; Zhao, L1
Cui, CJ; Dong, Q; Du, Y; Gao, Y; Guo, YL; Li, JJ; Li, S; Li, XL; Qing, P; Sun, J; Wu, NQ; Xu, RX; Yang, SH; Zhang, Y; Zhu, CG1
Bego, T; Čaušević, A; Dujić, T; Malenica, M; Prnjavorac, B; Semiz, S; Šilar, M; Škrbo, S1
Bilić-Ćurčić, I; Franceschi, M; Jukić, T; Makarović, S; Mihaljević, I1
Guo, R; Han, Q; Li, H; Li, L; Liu, F; Wang, S; Wang, T; Wang, Y; Wu, Y; Zhang, J; Zhang, R1
Abd-Elsalam, S; Abdelmoemen, G; Abou-Saif, S; Kassab, M; Khodeir, SA; Zaki, AN1
Hara, K; Inukai, T; Suzuki, T; Takebayashi, K; Tsuchiya, T1
Antova, E; Bosevska, G; Bosevski, M; Krstevski, G; Mitevska, I1
Fordyce, J; García, AA; Harrison, ML; Rock, J; Wolfe, AS; Zuñiga, JA1
Ebara, S; Ekawa, K; Marumo, M; Wakabayashi, I1
Chelstowski, K; Clark, JS; Jastrzebska, M; Lisman, D; Oledzki, S; Siennicka, A; Szelepajlo, A1
Bacci, S; De Cosmo, S; Pacilli, A; Trischitta, V1
Petrovič, D1
Camacho, A; Diaz, AJ; Fornieles, G; Garcia, N; Ordonez, FJ; Rosety, I; Rosety, MA; Rosety-Rodriguez, M1
Agrawal, L; Azad, N; Bahn, GD; Duckworth, W; Emanuele, NV; Hayward, R; Klein, R; McCarren, M; Reaven, P1
Adeyanju, MM; Odufuwa, KT; Osilesi, O; Salau, BA1
Chalmers, J; Hamet, P; Harrap, S; Hillis, G; Li, Q; Lowe, G; Marre, M; Patel, A; Poulter, N; Rumley, A; Woodward, M1
Poudel, S; Sapkota, B; Shrestha, SK1
Estébanez-De Miguel, E; Hidalgo-García, C; Lucha-López, AC; Lucha-López, MO; Salavera-Bordás, C; Tricás-Moreno, JM; Vidal-Peracho, C1
Abraham, P; de Roos, B; Holtrop, G; Johnstone, AM; Lobley, GE; MacRury, SM; McGeoch, SC; Megson, IL; O'Kennedy, N; Pearson, DW; Zhang, X1
Arturi, F; Fiorentino, TV; Perticone, F; Perticone, M; Sciacqua, A; Sesti, G; Succurro, E1
Abdul-Ghani, M; Cakirca, M; Camli, AA; Cikrikcioglu, MA; Erkoc, R; Hursitoglu, M; Kanat, M; Karatoprak, C; Kiskac, M; Soysal, P; Zorlu, M1
Aguilar-Sosa, E; Anaya-Gómez, F; Galván-Plata, ME; Isordia-Salas, I; Leaños-Miranda, A; Majluf-Cruz, A; Santiago-Germán, D1
Guo, YL; Hong, LF; Li, JJ; Li, XL; Luo, SH; Qing, P; Wu, NQ; Zhu, CG1
Akalin, A; Arabul, M; Celik, M; Cerrah, S1
Ajjan, RA; Alzahrani, SH; Baxter, PD; Gamlen, T; Hess, K; King, R; Oxley, N; Price, JF; Schroeder, V; Strachan, MW1
Danışman, N; Engin-Üstün, Y; Katar, C; Özyer, Ş; Uzunlar, Ö1
Breitner, S; Carter, J; Cyrys, J; Dailey, L; Devlin, RB; Diaz-Sanchez, D; Hampel, R; Koenig, W; Kraus, U; Peters, A; Phipps, R; Rückerl, R; Schneider, A; Silbajoris, R; Soentgen, J; Soukup, J1
Horobeĭko, MB1
Ajjan, RA; Grant, PJ; Grove, EL; Hvas, AM; Kristensen, SD; Kurdee, Z; Larsen, SB; Neergaard-Petersen, S; Phoenix, F1
Andreozzi, F; Fiorentino, TV; Hribal, ML; Perticone, F; Perticone, M; Sciacqua, A; Sesti, G1
Balykin, RA; Molchanov, AM; Zorina, OA1
Dai, DP; Lu, L; Shen, WF; Shen, Y; Tao, R; Xiong, WX; Zhang, Q; Zhang, RY1
Alummoottil, S; Bester, J; Buys, AV; Kell, DB; Pretorius, E; Soma, P; Vermeulen, N1
Barrett-Connor, E; Christophi, CA; Dabelea, D; Goldberg, RB; Kim, C; Marcovina, SM; Perreault, L; Pi-Sunyer, X1
Abu-Farha, M; Abubaker, J; Al-Khairi, I; Behbehani, K; Cherian, P; Elkum, N; Hu, FB; Noronha, F1
Gilowski, W; Krysiak, R; Okopien, B; Szkrobka, W1
de Las Heras Gala, T; Franks, PW; Giani, G; Herder, C; Huth, C; Klüppelholz, B; Koenig, W; Meisinger, C; Peters, A; Rathmann, W; Roden, M; Thorand, B1
Chen, X; Lv, W; Shi, X; Zheng, N1
Ahn, CW; Kang, S; Kim, KR; Lee, MY; Lee, S; Nam, JS; Park, JS; Shin, S1
Borkowska, A; Ciebiada, M; Gorska-Ciebiada, M; Loba, J; Saryusz-Wolska, M1
Beilin, LJ; Burke, V; Hodgson, JM; Mori, TA; Puddey, IB; Zilkens, RR1
Kang, Z; Wang, FJ; Yao, HQ1
Chadli, A; El Aziz, S; El Hammiri, A; Farouqi, A; Ghalim, N; Habbal, R; Kabine, M; Kamal, N; Kotbi, S; Mifdal, H; Mjabber, A; Nourichafi, N; Oukkache, B1
Chang, CJ; Hung, HC; Lu, FH; Ou, HY; Su, YC; Wu, CL; Wu, HT; Wu, JS; Yang, YC1
Breitner, S; Cyrys, J; Gu, J; Hampel, R; Koenig, W; Kraus, U; Peters, A; Rückerl, R; Schneider, A; Soentgen, J1
Gao, HL; Ley, CM; Liao, X; Ni, Q; Robinson, N1
Chehaibi, K; Mahdouani, K; Slimane, MN; Trabelsi, I1
Gligorijević, N; Nedić, O; Penezić, A1
Ajjan, RA; Alzahrani, S; Ariens, RA; Baxter, PD; Grant, PJ; Greenhalgh, KA; Price, JF; Standeven, KF; Storey, RF; Strachan, MW1
Fan, Y; Hong, LF; Li, JJ; Lu, ZH; Luo, SH; Wu, Q; Yan, XN; Yang, B; Ye, F1
Apostolopoulos, V; Bosevska, G; Bosevski, M; Stojanovska, L1
Farah, R; Lapin, O; Shurtz-Swirski, R1
Illoh, K; Illoh, OC1
Funatsu, H; Hori, S; Mimura, T; Noma, H; Shimizu, E1
Fernhall, B; Heffernan, KS; Jae, SY; Lee, MK; Park, WH1
Cornell, E; Knowler, WC; Krakoff, J; Le, DS; Miles, R; Savage, PJ; Tracy, RP1
Liese, AD; Schulz, M; Tooze, JA; Weis, KE1
Böhm, F; Hjemdahl, P; Malmström, RE; Pernow, J; Settergren, M1
Bertoni, AG; Folsom, AR; Lutsey, PL; Pankow, JS; Szklo, M1
Erem, C; Ersoz, HO; Hacihasanoglu, AB; Karti, SS; Ukinc, K1
Dogru, T; Ercin, CN; Erdem, G; Sonmez, A; Tapan, S; Tasci, I1
Krysiak, R; Okopien, B; Pruski, M1
Bouskela, E; Kraemer-Aguiar, LG; Lima, LM; Wiernsperger, N1
Boras, J; Erzen, DJ; Jazbec, A; Ljubic, S; Lovrencic, MV; Mileta, D; Vidjak, V1
Aguayo-Godinez, A; Aleman-Mireles, A; Escobedo-De la Peña, J; Guardado-Mendoza, R; Jimenez-Ceja, L; Majluf-Cruz, A; Molina-Padilla, J; Pacheco-Carrasco, MF; Villa-Godinez, G1
Jax, TW; Peters, AJ; Plehn, G; Schoebel, FC1
Demidova, VS; Doguzhieva, RM; Egorova, VV; Emel'ianov, DR; Lebedeva, AN; Pokrovskiĭ, AV; Titova, MI1
Chacko, SK; Cheluvappa, R1
Breitner, S; Frampton, MW; Hampel, R; Koenig, W; Peters, A; Phipps, RP; Rückerl, R; Schneider, A; Wichmann, HE1
Bastos, AS; Correa, FO; Figueredo, CM; Gonçalves, D; Gustafsson, A; Orrico, SR1
Abdel-Fatah Ali, A; Sayed Mahmoud And, M; Swellam, M1
Barr, RG; Bertoni, AG; Burke, GL; Carnethon, MR; Jenny, NS; Ouyang, P; Owusu, JA; Rotter, JI; Vaidya, D1
Hardison, RM; McBane, RD; Sobel, BE1
Angelopoulou, N; Fotiadis, G; Kadoglou, NP; Kapelouzou, A; Karayannacos, PE; Noussios, G; Sailer, N; Vrabas, IS1
Aschner, P; Casas, A; Charry, L; Dennis, RJ; Maldonado, D; Rojas, MX; Rondón, M1
Deng, H; Ding, Y; Liao, Y; Liu, K; Su, G; Wang, Y; Wang, Z; Zeng, Q1
Guliani, BP; Gupt, B; Kansra, UC; Madan, R; Saluja, S; Tripathi, BK1
Deary, IJ; Fowkes, FG; Gow, AJ; Harris, SE; Houlihan, LM; Lowe, GD; Luciano, M; Marioni, RE; Murray, GD; Price, JF; Rumley, A; Stewart, MC; Strachan, MW1
Ballenger, FJ; Bhola, V; Cathro, H; Kunaparaju, S; Okafor, C; Rosner, MH1
de Gorospe Pérez-Jáuregui, C; Del Cañizo Gómez, FJ; Fernández Pérez, C; González Losada, T; Moreno Ruiz, I; Segura Galindo, A; Silveira Rodríguez, B1
Masztalewicz, M; Nowacki, P; Safranow, K; Turowska-Kowalska, J1
Bălşeanu, AT; Dănoiu, S; Iancu, I; Mitran, SI; Moţa, M; Pisoschi, C; Riza, A; Sfredel, V1
Ballantyne, CM; Belalcazar, LM; Haffner, SM; Lang, W; Pi-Sunyer, FX; Rushing, J; Schwenke, DC; Tracy, RP1
Chudý, P; Kotuličová, D; Kubisz, P; Staško, J1
Azadbakht, L; Esmaillzadeh, A; Surkan, PJ; Willett, WC1
Milutinović, A; Petrovič, D; Pleskovič, A; Vraspir-Porenta, O; Zorc, M; Zorc-Pleskovič, R1
Brooks, MM; Frye, RL; Genuth, S; Hardison, RM; Huber, K; Krishnaswami, A; McBane, RD; Pratley, RE; Schneider, DJ; Sobel, BE; Wolk, R1
Borges, MA; Carvalho, MG; Fernandes, AP; Kazmi, RS; Lwaleed, BA; Rosário, PW; Soares, AL; Sousa, MO1
Aso, Y; Hara, K; Omori, K; Sumioka, Y1
Abbatecola, AM; Caruso, C; Castellani, G; Franceschi, C; Galeazzi, R; Lattanzio, F; Lisa, R; Mari, D; Monti, D; Ogliari, G; Olivieri, F; Ostan, R; Scurti, M; Sirolla, C; Spazzafumo, L; Testa, R; Vasto, S; Vescovini, R1
Antonova, N; Damianov, P; Dimitrova, V; Mantarova, S; Stoyneva, Z; Velcheva, I1
Antonova, N; Damianov, P; Mantarova, S; Velcheva, I1
Tanriverdı, O1
Athanasiadou, Z; Fotiadis, G; Kadoglou, NP; Lampropoulos, S; Vitta, I; Vrabas, IS1
Bathaie, SZ; Kebriaeezadeh, A; Khaghani, S; Mirmiranpour, H; Nakhjavani, M1
Adamson, J; Barrett, F; MacRury, SM; Megson, IL; Sharma, S; Todd, A; Zentler-Munro, PL1
Demidova, VS; Doguzhieva, RM; Lebedeva, AN; Pokrovskiĭ, AV1
Belcredi, P; Breitner, S; Carter, JD; Cyrys, J; Dailey, L; Devlin, RB; Diaz-Sanchez, D; Geruschkat, U; Hampel, R; Koenig, W; Kraus, U; Peters, A; Phipps, R; Rückerl, R; Schäuble, CL; Schneider, AE; Silbajoris, R; Soukup, J1
Breza, J; Goncalves, FM; Ziaran, S1
Dahl, M; Lange, P; Nordestgaard, BG; Thomsen, M; Vestbo, J1
Everett, B; Hensen, J; Howard, CP; Libby, P; Ridker, PM; Thuren, T; Walter, V1
Goodman, E; Oreskovic, NM1
Bosevska, G; Bosevski, M; Stojanovska, L1
Chen, X; Hu, Y; Jang, Y; Li, G; Wang, J; Xing, X; Yang, W1
Damsgaard, EM; Foss, CH; Frøland, A; Gjessing, HJ; Ingerslev, J; Mogensen, CE; Vestbo, E1
Hanefeld, M; Henkel, E; Koehler, C; Temelkova-Kurktschiev, T1
Biondi, B; Fazio, S; Lombardi, G; Nuzzo, V; Palmieri, EA; Pulcrano, M; Rossi, R; Tauchmanovà, L1
Masuda, H; Wakabayashi, I1
Boynard, M; Devehat, CL; Guillet, R; Khodabandehlou, T1
Fukushima, M; Kuroe, A; Nagasaka, S; Nakai, Y; Nin, K; Ogura, M; Okumura, T; Sakai, M; Seino, Y; Taniguchi, A; Watanabe, T; Yamada, Y; Yamadori, N; Yoshii, S1
Buchanan, TA; Chong-Martinez, B; Meiselman, HJ; Wenby, RB1
Festa, A; Kopp, CW; Kopp, HP; Kriwanek, S; Krzyzanowska, K; Minar, E; Roka, R; Schernthaner, G1
Brekke, H; Funahashi, T; Jansson, PA; Matsuzawa, Y; Pellmé, F; Smith, U; Taskinen, MR; Wiklund, O1
Tracy, RP1
Barazzoni, R; Cristini, M; Kiwanuka, E; Tessari, P; Vettore, M; Zanetti, M1
Bargero, G; Biggeri, A; Bruno, G; Cavallo Perin, P; Ferrero, S; Merletti, F; Pagano, G1
Becker, A; Bouter, LM; Heine, RJ; Stehouwer, CD; van der Does, FE; van Hinsbergh, VW1
De Maat, MP; Huisman, MV; Kluft, C; Meinders, AE; Princen, HM; Van De Ree, MA1
Bella, JN; Best, LG; Devereux, RB; Howard, BV; Liu, JE; Palmieri, V; Robbins, DC; Roman, MJ; Tracy, RP1
D'Agostino, R; Festa, A; Haffner, SM; Hanley, AJ; Tracy, RP1
Derby, C; Jannausch, ML; Pasternak, R; Sowers, M; Torrens, JI1
Alekseeva, RI; Andreenko, GV; Karabasova, MA; Liutova, LV; Meshcheriakova, VA; Plotnikova, OA; Sharafetdinov, KhKh1
Baillet, L; Gin, H; Rigalleau, V; Roudaut, MF; Vergnot, V1
Aso, Y; Inukai, T; Kanda, T; Kobayashi, I; Okumura, K; Takemura, Y; Tayama, K; Yoshida, N1
Amagasa, H; Murakami, H; Oguchi, K; Okazaki, M1
Javorský, M; Kalina, I; Kozárová, M; Salagovic, J; Tkác, I; Tkácová, R1
Jiu, G; Li, X; Liu, Y; Zhang, M1
Martin, F; Martin-Luengo, C; Morinigo, JL; Pabon, P; Palacios, IF; Piedra, I; Sanchez, PL1
Berg, C; Herrmann, BL; Mann, K; Nowak, T; Renzing-Koehler, K; Saller, B; Vogel, E1
Cieślik, G; Idzior-Waluś, B; Sieradzki, J; Waluś, M1
Keating, FK; Schneider, DJ; Sobel, BE; Whitaker, DA1
Fisher, M; Kirk, A; MacIntyre, P; Mutrie, N1
Kammerer, L; Lengyel, Z; Mihály, M; Németh, C; Rosivall, L; Tornóci, L; Tóth, LK; Vörös, P1
Aso, Y; Inoue, T; Inukai, T; Matsutomo, R; Okumura, K; Takebayashi, K; Wakabayashi, S; Yoshida, N1
Aso, Y; Inukai, T; Takebayashi, K1
Hu, FB; Rifai, N; Rimm, EB; Schulze, MB; Shai, I1
Khodabandehlou, T; Le Dévéhat, C; Vimeux, M3
Gomes, MB; Nogueira, VG1
Bartnik, M; Efendic, S; Hamsten, A; Malmberg, K; Norhammar, A; Ohrvik, J; Rydén, L; Silveira, A; Tenerz, A1
Aso, Y; Inukai, T; Matsutomo, R; Okumura, K; Takebayashi, K; Wakabayashi, S; Yoshida, N1
Dobordzhginidze, LM1
Cozma, A; Negrean, V; Sâmpelean, D; Suciu, I1
Agardh, CD; Gustavsson, CG1
Altun, A; Tatli, E; Tugrul, A; Ugur-Altun, B1
Monteduro, C; Muiesan, ML; Porteri, E; Rizzoni, D; Rosei, EA; Salvetti, M; Sleiman, I1
Akcit, F; Coban, E; Ozdogan, M; Sari, R1
Bargero, G; Biggeri, A; Bruno, G; Cavallo-Perin, P; Ferrero, S; Merletti, F; Pagano, G1
Kirbis, J; Milutinović, A; Poglajen, G1
Charvát, J; Chlumský, J; Kvapil, M; Michalová, K; Táborská, K; Vojácek, J1
Bergeron, J; Corneau, L; Lemieux, S; Nadeau, A; Piché, ME; Weisnagel, SJ1
Araki, T; Emoto, M; Fujiwara, S; Hatsuda, S; Koyama, H; Maeno, T; Nishizawa, Y; Shinohara, K; Shoji, T; Tahara, H; Yokoyama, H1
Ansquer, JC; Foucher, C; Rattier, S; Steiner, G; Taskinen, MR1
Javorský, M; Kozárová, M; Salagovic, J; Tkáč, I1
Ariëns, RA; Dunn, EJ; Grant, PJ1
Dunn, EJ; Grant, PJ1
Ciccarelli, L; Cicero, AF; Derosa, G; Ferrari, I; Gaddi, AV; Ghelfi, M; Peros, E; Piccinni, MN; Salvadeo, S1
Balletshofer, BM; Enderle, M; Ferenc Pap, A; Goebbel, S; Häring, HU; Matthaei, S; Petzinna, D; Rittig, K; Schmölzer, I; Wascher, TC; Westermeier, T1
Habeos, IG; Kyriazopoulou, V; Michalaki, M; Psyrogiannis, A; Theodoropoulou, A; Vagenakis, AG1
Aso, Y; Inukai, T; Inukai, Y; Matsumoto, S; Matsutomo, R; Takebayashi, K; Wakabayashi, S1
Hitoglou-Makedou, AD; Kazakos, KA; Lasaridis, AN; Mouslech, TF; Nilsson, PM; Sarafidis, PA; Stafylas, PC; Tourkantonis, AA; Yovos, JG1
Aunola, S; Eriksson, JG; Hämäläinen, H; Ilanne-Parikka, P; Keinänen-Kiukaanniemi, S; Lindström, J; Rastas, M; Rönnemaa, T; Tuomilehto, J; Uusitupa, M; Valle, TT; Virtanen, A1
Coppola, G; Corrado, E; Lo Coco, L; Muratori, I; Novo, S; Tantillo, R; Vitale, G1
Bevelacqua, V; Bevelacqua, Y; Libra, M; Malaponte, G; Mazzarino, MC; Navolanic, PM; Polesel, J; Signorelli, SS; Stivala, F; Talamini, R1
Barazzoni, R; Carnielli, V; Cogo, P; Gucciardi, A; Kiwanuka, E; Millioni, R; Puricelli, L; Tessari, P; Tiengo, A; Tosolini, M; Vettore, M; Zanetti, M1
Rizvi, AA1
Aso, Y; Inukai, T; Matsutomo, R; Suetsugu, M; Takebayashi, K; Wakabayashi, S1
Ariëns, RA; Dunn, EJ; Grant, PJ; Philippou, H1
Festa, A; Haffner, SM; Tracy, RP; Wagenknecht, LE; Williams, K1
Holá, D; Pálová, S; Zamrazil, V1
Barazzoni, R; Kiwanuka, E; Tessari, P; Vettore, M; Zanetti, M1
Freed, MI; Haffner, SM; Herman, WH; Holman, RR; Jones, NP; Kahn, SE; Kravitz, BG; Lachin, JM; O'Neill, MC; Viberti, GC; Yu, D; Zinman, B1
Garanty-Bogacka, B; Gebala, A; Syrenicz, A; Syrenicz, M; Walczak, M1
Coppola, G; Corrado, E; Muratori, I; Novo, S; Rizzo, M1
Arcaro, G; Bertolini, L; Cigolini, M; Padovani, R; Scala, L; Targher, G; Zenari, L1
Beishuizen, ED; Huisman, MV; Misra, A; Ray, A; Tamsma, JT1
Covic, N; Jerling, JC; Loots, du T; Pieters, M; Rheeder, P; van der Westhuizen, FH; van Zyl, DG; Weisel, JW1
Gottsche, LT; Jerling, JC; Loots, du T; Pieters, M; Rheeder, P; van der Westhuizen, FH; van Zyl, DG; Weisel, JW1
Letonturier, P1
Barontini, R; Bianchi, C; Corfini, M; Del Prato, S; Di Cianni, G; Giovannitti, MG; Malloggi, L; Miccoli, R; Penno, G1
Bianchi, C; Caricato, F; Civitelli, A; Del Prato, S; Miccoli, R; Pancani, F; Pellegrini, G; Penno, G; Piaggesi, A1
Chou, CW; Hsiao, SH; Kao, PC; Lin, CY; Ou, HY; Wu, TJ1
Avdagić, N; Fajkić, A; Lepara, O; Nakag-Ićindić, E; Valjevac, A1
Armbruster, FP; Borchert, M; Forst, T; Grabellus, M; Hohberg, C; Hoopmann, M; Löbig, M; Lübben, G; Pfützner, A; Roth, W; Schöndorf, T1
Hanefeld, M; Ludvik, B; Pacini, G1
Grant, PJ1
Malaponte, G; Mazzarino, MC; Signorelli, SS; Spandidos, DA1
Després, JP; Lemieux, I; Mertens, I; Van Gaal, LF; Verrijken, A1
Borozanov, V; Bosevski, M; Georgievska-Ismail, L; Peovska, I1
Borkowska, A; Chizyński, K; Cieplucha, E; Czupryniak, L; Loba, J; Miłosz, D; Saryusz-Wolska, M; Zasadzińska, G1
Castellino, P; Ciarambino, T; Cioffi, M; De Feo, P; Gesuè, L; Giordano, M; Gresele, P; Lucidi, P; Paolisso, G1
Haidar, A; Saad, F; Shabsigh, R; Yassin, A1
Akalin, A; Alatas, O; Colak, O1
Ahmad, I; Ahmad, J; Ahmned, F; Hameed, B; Katyal, P; Khan, AR; Siddiqui, MA1
Alizadeh Dehnavi, R; Beishuizen, ED; Huisman, MV; Kluft, C; Le Cessie, S; Princen, HM; Tamsma, JT; van de Ree, MA1
Badimón, L; Catalina, P; Gómez, JM; Sahún, M; Soler, J; Vila, R1
Baras, Y; Covic, N; Edmondson, KS; Elgar, D; Jerling, JC; Nagaswami, C; Pieters, M; Rheeder, P; Toit Loots, D; van der Westhuizen, FH; van Zyl, DG; Weisel, JW1
Fuller, JH1
Almér, LO1
Beiküfner, P; Panzram, G; Schmechel, H1
Baraldi, P; Codeluppi, L; Melli, M; Peduzzi, M; Poggi, M; Torlai, F1
Auriemma, L; Di Martino, G; Florio, A; Iannucci, F; Matarazzo, A; Rosati, V1
Hermansen, K; Ingerslev, J; Rasmussen, O; Thomsen, C1
Hermansen, K; Ingerslev, J; Rasmussen, OW; Thomsen, C1
Barker, M; Berkin, KE; Gough, SC; Grant, PJ; Rice, PJ; Smyllie, J1
Abruzzese, G; Avellone, G; Bompiani, GD; Cordova, R; De Simone, R; Di Garbo, V; Raneli, G; Rotolo, G1
Qiu, HX; Rong, J; Wang, SP1
Bruno, CM; Cristaldi, R; D'Amico, R; D'Angelo, G; Neri, S; Raciti, C1
Laitinen, J; Uusitupa, M; Vanninen, E1
Angós, JA; Cornudella, R; Gálvez, MM; Gutiérrez, M; Moreno, JA; Romero, MS1
Barker, DJ1
Griesmacher, A; Knöbl, P; Müller, M; Pietschmann, P; Prager, R; Schernthaner, G; Schnack, C1
Alberti, KG; Bahru, Y; Kesteven, P; Walker, M1
Barker, DJ; Fall, CH1
Egawa, H; Komiyama, Y; Murakami, T; Murata, K1
Memeh, CU1
Cordova, C; Gazzaninga, PP; La Mancusa, R; Pettirossi, G; Pulcinelli, FM; Spanò, GM1
Grant, PJ; Heywood, DM; Mansfield, MW2
Aoshima, K; Asakura, H; Hashimoto, T; Jokaji, H; Kumabashiri, I; Matsuda, T; Morishita, E; Saito, M; Uotani, C; Yamazaki, M1
Harano, Y; Hattori, Y; Inada, H; Inoue, J; Ito, H; Kawamori, R; Murase, T; Nawata, H; Orimo, H; Ouchi, Y; Suzuki, M; Takeuchi, M; Umeda, F1
Bots, ML; Grobbee, DE; Hofman, A; Missov, RM; Pols, HA; Stolk, RP; van der Bom, JG1
Biesenbach, G; Zazgornik, J1
de Leonardis, V; Lombardi, V; Perfetto, F; Piluso, A; Tarquini, B; Tarquini, R1
Bargero, G; Borra, M; Bruno, G; Cavallo-Perin, P; D'Errico, N; Pagano, G2
Couchman, S; Crook, MA; Tutt, P1
Cavallo-Perin, P; D'Este, P; Girotto, M; Gruden, G; Mormile, A; Rossetto, P; Veglio, M1
Carter, AM; Grant, PJ; Mansfield, MW; Stickland, MH1
Deguchi, H; Gabazza, EC; Mohri, M; Murata, K; Nakatani, K; Nishioka, J; Sata, M; Shima, T; Sumida, Y; Suzuki, K; Taguchi, O; Takeya, H; Yano, Y1
Greenhalgh, RM; Hicks, RC; Higman, DJ; Moss, J; Powell, JT1
Fujishlma, M; Iwase, M; Takano, K; Waklsaka, M; Yamamoto, M; Yoshinari, M1
Ceriello, A1
Juhan-Vague, I; Vague, P1
Jeck, T; Keller, U; Riesen, WF1
Honda, Y; Kenmochi, S; Miyamoto, K; Ogura, Y1
Molcányiová, A; Tkác, I1
Bortolotti, N; Ceriello, A; Crescentini, A; Giacomello, R; Motz, E; Pirisi, M; Russo, A; Stel, G; Taboga, C; Tonutti, L1
Byington, RP; Di Mauro, P; Guarisco, R; Pahor, M; Strollo, F; Strollo, G; Tatti, P1
Dhanjil, S; Diamond, JR; Elkeles, RS; Feher, MD; Mahmood, S; Mather, H; Nicolaides, AN; Poulter, C; Richmond, W; Sharp, P1
Kuligowska, E; Kuligowski, D; Stanosz, S1
Aznar, J; Gilsanz, A; Martínez, M; Server, R; Vayá, A1
de Leiva, A1
Ceriello, A; Damante, G; Fabbro, D; Giacomello, R; Mercuri, F; Motz, E; Stel, G; Taboga, C; Tonutti, L1
D'Agostino, R; Festa, A; Haffner, SM; Hales, CN; Mykkänen, L; Tracy, RP; Zaccaro, DJ1
Barişta, I; Demiroglu, H; Gürlek, A1
Fujiwara, Y; Kawakami, Y; Tagami, S1
Beilin, LJ; Burke, V; Dunstan, DW; Mori, TA; Morton, AR; Puddey, IB; Stanton, KG1
Eckenberger, P; Gerber, P; Ho, MP; Kaemmereit, A; Lerch, M; Teuscher, AU; Weidmann, P1
Huang, WC; Lebovitz, H; Marbury, T; Strange, P1
Bowen, K; Campbell, L; Lintott, CJ; Scott, R; Welborn, T; Zimmet, P1
Babaya, N; Fujisawa, T; Fukuda, M; Ikegami, H; Kawabata, Y; Kawaguchi, Y; Nishino, T; Nojima, K; Noso, S; Ogihara, T; Ohguro, N; Okamoto, N; Ono, M; Shintani, M; Ueda, H; Yamada, K; Yamato, E1
Kado, S; Nagase, T; Nagata, N1
Coppola, L; Cozzolino, D; De Lucia, D; Gentile, S; Masi, S; Salvatore, T; Sasso, FC; Torella, R1
Chan, LC; Janus, ED; Lam, KS; Ma, OC; Wat, NM1
Barinas-Mitchell, E; Kuller, LH; Pietropaolo, M; Pietropaolo, SL; Trucco, M1
Davis, CE; Folsom, AR; Heiss, G; Metcalf, PA; Wu, KK1
Ferber, P; Koschinsky, T; Moll, K; Rösen, P; Schwippert, B; Susanto, F; Tschöpe, D1
Din, G; Hu, J; Liu, Z; Wei, W; Yuan, L1
Ascaso, JF; Carmena, R; Hernández-Mijares, A; Lluch, I; Martínez-Triguero, ML; Vizcarra, E1
Bayraktar, M; Gürlek, A; Kirazli, S1
Brancati, FL; Chambless, LE; Duncan, BB; Folsom, AR; McGovern, PG; Saito, I1
Barazzoni, R; Carraro, P; Davanzo, G; Kiwanuka, E; Tessari, P; Tiengo, A; Zanetti, M1
D'Agostino, R; Festa, A; Haffner, SM; Howard, G; Mykkänen, L; Tracy, RP1
Chan, JC; Cockram, CS; Ko, GT; Tsang, LL1
Bulmer, K; Denver, AE; Emeis, JJ; Mohamed-Ali, V; Panahloo, A; Stehouwer, C; Yudkin, JS1
Aso, Y; Fujiwara, Y; Inukai, T; Takemura, Y1
Hedley, AJ; Janus, ED; Lam, KS; Lam, TH; Liu, LJ1
Fujita, S; Fukamizu, M; Kaizu, K; Nakajima, S; Noguchi, T; Tabuchi, M; Taka, T; Ueda, T; Yamamoto, J1
Lala, A; Menzinger, G; Montecchi, FR1
Aso, Y; Fujiwara, Y; Inukai, T; Takanashi, K; Takemura, Y; Tayama, K1
Best, JD; Cumpston, GN; Dragicevic, G; Giles, GG; Herbert, KE; O'Dea, K; Stoney, RM1
Genovese, S; Parillo, M; Rivellese, AA1
Aybar, MJ; Carrizo, T; Prado, MM; Sánchez, SS; Velarde, MS1
Aguilar-Salinas, CA; Cesarman, G; Chavira-López, IJ; Fanghänel-Salmón, G; Gallegos-Martínez, J; Gómez-Diaz, RA; Gómez-Pérez, FJ; Guillén, LE; López, A; Salinas-Orozco, S; Sánchez-Reyes, L; Tamez, R; Torres-Acosta, EM; Vázquez-Chávez, C1
Asakawa, H; Kawakami, F; Tokunaga, K1
Engelschalk, C; Fraunberger, P; Laubach, E; Otto, C; Schwandt, P1
Arber, N; Avitzour, D; Berliner, S; Elishkevitz, K; Fusman, R; Koffler, M; Rotstein, R; Shapira, I; Zeltser, D1
Bai, X; Han, Y; Ruan, C; Wang, A; Wang, Z; Zhu, M1
Aso, Y; Fujiwara, Y; Inukai, T; Matsumoto, S; Takemura, Y; Tayama, K1
D'Agostino, R; Festa, A; Haffner, SM; Tracy, RP1
Brandenburg, SL; Felder, KK; Lindenfeld, J; Manco-Johnson, M; Nelson-Wong, E; Regensteiner, JG; Reusch, JE1
Corradi, L; Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Zoppi, A1
Chen, J; Ding, P; Li, C; Ma, Y1
Bergmann, S; Hanefeld, M; Henkel, E; Jaross, W; Koehler, C; Siegert, G; Temelkova-Kurktschiev, T1
Athyros, VG; Athyrou, VV; Demitriadis, DS; Kontopoulos, AG; Papageorgiou, AA1
Arkin, CF; Ganda, OP1
Lazúr, J; Takác, M; Tkác, I; Tkácová, R1
Barbagallo, M; Catalano, I; Daví, G; Giammarresi, C; Nicolosi, G; Notarbartolo, A; Putignano, E; Violi, F1
Lockhart, JC; Lowe, GD; MacCuish, AC; MacRury, SM; Small, M; Weir, AI1
Ford, I; Kitchen, S; Makris, M; Preston, FE; Singh, TP; Ward, JD1
Cho, YW; Hong, SY; Huh, KB; Kim, SJ; Lee, HC; Oh, DY1
Anderson, J; Lowe, GD; MacCuish, AC; MacRury, SM; Small, M1
Barnwell, WH; Boggess, KA; Colwell, JA; Hornsby, WG; Lazarchick, J; Lyons, TJ1
Asakura, H; Jokaji, H; Kumabashiri, I; Matsuda, T; Morishita, E; Saito, M; Uotani, C; Yamazaki, M1
Konen, JC; McCormick, CP; Shihabi, ZK1
Barradas, MA; Dandona, P; Mathur, S; Mikhailidis, DP1
Ingerslev, J; Schmitz, A1
Bertoja, H; Girolami, A; Mares, M; Midena, E; Piermarocchi, S; Procidano, M; Segato, T; Zucchetto, M1
Lazúr, J; Molcányová, A; Moscovic, F; Takác, M; Tkác, I1
Memeh, CU; Reid, HL1
Karam, JH; Koda-Kimble, MA; White, JR1
Jorke, D; Jütte, A; Oswald, B; Syrbe, G1
Guo, SS; Hong, G; Liang, XC; Qian, ZF; Tao, LH; Wang, Y; Zhu, SY1
Althoff, P; Breddin, HK; Krzywanek, HJ; Schöffling, K; Uberla, K1
Khachadurian, AK; Kim, HC; Ruderman, NB; Schneider, SH1
Elkeles, RS; Feher, MD; Rampling, MW; Sever, PS1
Althoff, P; Breddin, HK; Kirchmaier, CM; Krzywanek, HJ; Rosak, C; Schepping, M; Schöffling, K; Uberla, K; Weichert, W; Ziemen, M1
Ferrari, E; Fioravanti, M; Patti, AL; Solerte, SB; Viola, C1
Boden, G; Capitanio, AM; Hershock, D; Kornecki, E; Lukasiewicz, H; Niewiarowski, S; Rawala, R1
Seviour, PW1
Forbes, CD; Lowe, GD; MacCuish, AC; Small, M1
Frank, I; Hänsgen, K; Klare, M; Podhaisky, H; Preuss, EG; Sternitzky, R1
Jones, RL1
Ferrari, E; Solerte, SB1
Duchna, W; Gräfenstein, K1

Reviews

13 review(s) available for fibrinogen and Diabetes Mellitus, Type 2

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Associations Between Inflammatory Markers, Hemostatic Markers, and Microvascular Complications in 182 Chinese Patients With Type 2 Diabetes Mellitus.
    Laboratory medicine, 2015,Summer, Volume: 46, Issue:3

    Topics: Adult; Aged; Antithrombin III; Asian People; C-Reactive Protein; Diabetes Mellitus, Type 2; Endothelium, Vascular; Factor VII; Female; Fibrinogen; Humans; Interleukin-6; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Regression Analysis; Statistics, Nonparametric; von Willebrand Factor

2015
Inflammation, the metabolic syndrome and cardiovascular risk.
    International journal of clinical practice. Supplement, 2003, Issue:134

    Topics: Arteriosclerosis; Aspirin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Estrogens; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Metabolic Syndrome; Risk Factors

2003
[Fibrates: mechanism of action, effect on levels of lipids and risk of coronary events. II. Fenofibrate].
    Kardiologiia, 2004, Volume: 44, Issue:3

    Topics: Adult; Aged; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fenofibrate; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Placebos; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Triglycerides

2004
Type 2 diabetes: an atherothrombotic syndrome.
    Current molecular medicine, 2005, Volume: 5, Issue:3

    Topics: Animals; Blood Coagulation; Blood Platelets; Diabetes Mellitus, Type 2; Endothelium, Vascular; Factor VII; Factor VIII; Factor XII; Factor XIII; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Insulin Resistance; Plasminogen Activator Inhibitor 1; Syndrome; Thrombosis; Tissue Plasminogen Activator; von Willebrand Factor

2005
Diabetes mellitus as a prothrombotic condition.
    Journal of internal medicine, 2007, Volume: 262, Issue:2

    Topics: Blood Coagulation Factors; Blood Platelets; Diabetes Mellitus, Type 2; Endothelium, Vascular; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hyperglycemia; Insulin Resistance; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombosis; Tissue Plasminogen Activator

2007
Proinflammatory circulating molecules in peripheral arterial disease.
    International journal of molecular medicine, 2007, Volume: 20, Issue:3

    Topics: C-Reactive Protein; Cell Adhesion Molecules; Cytokines; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Inflammation Mediators; Interleukin-6; Matrix Metalloproteinases; Models, Biological; Peripheral Vascular Diseases; Polymorphism, Single Nucleotide

2007
The haemocoagulation system and macroangiopathy in insulin dependent (type I) diabetes.
    Annals of clinical research, 1984, Volume: 16, Issue:3

    Topics: Antithrombin III; Arachidonic Acids; beta-Thromboglobulin; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Platelet Adhesiveness; Platelet Aggregation

1984
The intrauterine origins of cardiovascular disease.
    Acta paediatrica (Oslo, Norway : 1992). Supplement, 1993, Volume: 82 Suppl 391

    Topics: Adult; Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fetal Growth Retardation; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Infant, Newborn; Insulin; Insulin Resistance; Lipids; Male; Maternal Welfare; Middle Aged; Nutritional Physiological Phenomena

1993
Fetal and infant origins of cardiovascular disease.
    Archives of disease in childhood, 1993, Volume: 68, Issue:6

    Topics: Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Female; Fetal Growth Retardation; Fibrinogen; Humans; Hypertension; Infant; Infant, Newborn; Infant, Small for Gestational Age; Male; Pregnancy; Risk Factors; Time Factors

1993
Fibrinogen and diabetes mellitus: is it time for intervention trials?
    Diabetologia, 1997, Volume: 40, Issue:6

    Topics: Arteriosclerosis; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinogen; Humans; Models, Biological; Predictive Value of Tests; Risk Factors; Thrombin

1997
Fibrinogen, fibrinolysis and diabetes mellitus: a comment.
    Diabetologia, 1997, Volume: 40, Issue:6

    Topics: Arteriosclerosis; Biomarkers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinogen; Fibrinolysis; Humans; Plasminogen Activator Inhibitor 1; Risk Factors; Tissue Plasminogen Activator

1997
What are the benefits of moderate weight loss?
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 1998, Volume: 106 Suppl 2

    Topics: Body Constitution; Body Mass Index; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diet, Reducing; Female; Fibrinogen; Gastric Bypass; Humans; Hypertension; Insulin; Male; Morbidity; Obesity; Quality of Life; Risk Factors; Weight Loss

1998

Trials

62 trial(s) available for fibrinogen and Diabetes Mellitus, Type 2

ArticleYear
Correlation analysis between plasma fibrinogen and nerve electrophysiological changes in type 2 diabetic peripheral neuropathy.
    Folia neuropathologica, 2023, Volume: 61, Issue:2

    Topics: Diabetes Mellitus, Type 2; Diabetic Neuropathies; Fibrinogen; Humans; Nerve Conduction Studies

2023
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Association between angiopoietin-like protein 2 and lectin-like oxidized low-density lipoprotein receptor 1 ligand containing apolipoprotein B in patients with type 2 diabetes.
    The Journal of international medical research, 2018, Volume: 46, Issue:10

    Topics: Aged; Angiopoietin-Like Protein 2; Angiopoietin-like Proteins; Apolipoproteins B; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glomerular Filtration Rate; Humans; Ligands; Male; Middle Aged; Scavenger Receptors, Class E

2018
Aerobic training improved low-grade inflammation in obese women with intellectual disability.
    Journal of intellectual disability research : JIDR, 2014, Volume: 58, Issue:6

    Topics: Acute-Phase Proteins; Adult; C-Reactive Protein; Cytokines; Diabetes Mellitus, Type 2; Down Syndrome; Exercise; Female; Fibrinogen; Humans; Inflammation Mediators; Interleukin-6; Obesity; Risk Factors; Tumor Necrosis Factor-alpha; Young Adult

2014
Oat-enriched diet reduces inflammatory status assessed by circulating cell-derived microparticle concentrations in type 2 diabetes.
    Molecular nutrition & food research, 2014, Volume: 58, Issue:6

    Topics: Adult; Aged; Avena; Biomarkers; Blood Platelets; Cell-Derived Microparticles; Cross-Over Studies; Diabetes Mellitus, Type 2; Diet; Female; Fibrinogen; Humans; Inflammation; Leukocytes; Male; Middle Aged; P-Selectin; Postprandial Period

2014
Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients.
    Drug design, development and therapy, 2014, Volume: 8

    Topics: Adamantane; Adult; Aged; Arginine; C-Reactive Protein; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Female; Fibrinogen; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Nitric Oxide; Nitriles; Pyrrolidines; Vildagliptin

2014
[Indication and technique of human fibrinogen/thrombin-coated collagen patch use in mucogingival surgery].
    Stomatologiia, 2014, Volume: 93, Issue:4

    Topics: Adult; Diabetes Mellitus, Type 2; Female; Fibrinogen; Gingiva; Humans; Hypertension; Male; Middle Aged; Mouth Mucosa; Oral Surgical Procedures; Re-Epithelialization; Thrombin; Wound Closure Techniques

2014
Adiponectin, C-reactive protein, fibrinogen and tissue plasminogen activator antigen levels among glucose-intolerant women with and without histories of gestational diabetes.
    Diabetic medicine : a journal of the British Diabetic Association, 2016, Volume: 33, Issue:1

    Topics: Adiponectin; Adult; Biomarkers; Body Mass Index; C-Reactive Protein; Cohort Studies; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabetes, Gestational; Diet, Reducing; Female; Fibrinogen; Glucose Intolerance; Humans; Hypoglycemic Agents; Life Style; Middle Aged; Motor Activity; Overweight; Pregnancy; Risk; Tissue Plasminogen Activator; United States; Weight Loss

2016
The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia.
    Cardiovascular therapeutics, 2015, Volume: 33, Issue:5

    Topics: Adult; Atorvastatin; Bromocriptine; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diet; Dopamine Agonists; Exercise; Female; Fibrinogen; Homocysteine; Humans; Hypercholesterolemia; Hyperprolactinemia; Hypoglycemic Agents; Hypolipidemic Agents; Metformin; Middle Aged; Premenopause; Risk Factors; Uric Acid

2015
The effects of alcohol on ambulatory blood pressure and other cardiovascular risk factors in type 2 diabetes: a randomized intervention.
    Journal of hypertension, 2016, Volume: 34, Issue:3

    Topics: Aged; Alcohol Drinking; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Heart Rate; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Wine

2016
Bromelain and cardiovascular risk factors in diabetes: An exploratory randomized, placebo controlled, double blind clinical trial.
    Chinese journal of integrative medicine, 2016, Volume: 22, Issue:10

    Topics: Blood Glucose; Bromelains; C-Reactive Protein; Cardiovascular Diseases; Demography; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Placebos; Risk Factors; Treatment Outcome

2016
No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance.
    Thrombosis and haemostasis, 2009, Volume: 101, Issue:1

    Topics: Aged; Anticholesteremic Agents; Azetidines; C-Reactive Protein; CD40 Ligand; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Down-Regulation; Drug Therapy, Combination; Ezetimibe; Female; Fibrinogen; Glucose Intolerance; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; P-Selectin; Platelet Aggregation; Simvastatin; Time Factors; Treatment Outcome

2009
Effects of one year simvastatin and atorvastatin treatments on acute phase reactants in uncontrolled type 2 diabetic patients.
    Endocrine, 2009, Volume: 35, Issue:3

    Topics: Acute-Phase Proteins; Adult; Anticholesteremic Agents; Atorvastatin; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Ferritins; Fibrinogen; Heptanoic Acids; Humans; Male; Middle Aged; Pyrroles; Simvastatin; Time Factors

2009
Pleiotropic action of short-term metformin and fenofibrate treatment, combined with lifestyle intervention, in type 2 diabetic patients with mixed dyslipidemia.
    Diabetes care, 2009, Volume: 32, Issue:8

    Topics: Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Combined Modality Therapy; Cytokines; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Fenofibrate; Fibrinogen; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Life Style; Metformin; Placebos; Plasminogen Activator Inhibitor 1; Risk Factors

2009
Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in C-reactive protein or fibrinogen
    Clinics (Sao Paulo, Brazil), 2009, Volume: 64, Issue:5

    Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibrinogen; Humans; Hypoglycemic Agents; Male; Metabolic Syndrome; Metformin; Middle Aged; Pedigree; Risk Factors; Statistics, Nonparametric

2009
Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).
    The American journal of cardiology, 2010, Jan-01, Volume: 105, Issue:1

    Topics: Age Factors; Aged; Autoantigens; Coronary Artery Disease; Diabetes Mellitus, Type 2; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Follow-Up Studies; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Retrospective Studies; Risk Factors; Severity of Illness Index; Time Factors; Tissue Plasminogen Activator

2010
Exercise ameliorates serum MMP-9 and TIMP-2 levels in patients with type 2 diabetes.
    Diabetes & metabolism, 2010, Volume: 36, Issue:2

    Topics: Aged; Biomarkers; C-Reactive Protein; Chi-Square Distribution; Diabetes Mellitus, Type 2; Exercise; Female; Fibrinogen; Humans; Male; Matrix Metalloproteinase 9; Middle Aged; Regression Analysis; Risk Factors; Tissue Inhibitor of Metalloproteinase-2

2010
Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study.
    Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:7

    Topics: Adipose Tissue; Adiposity; Biomarkers; Blood Glucose; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diet; Exercise; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Obesity; Physical Fitness; Plasminogen Activator Inhibitor 1; Regression Analysis; Risk Reduction Behavior; Time Factors; Treatment Outcome; United States; Weight Loss

2011
The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients.
    The Journal of nutrition, 2011, Volume: 141, Issue:6

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Coagulation Disorders; C-Reactive Protein; Cross-Over Studies; Diabetes Complications; Diabetes Mellitus, Type 2; Diet, Diabetic; Female; Fibrinogen; Humans; Hypertension; Liver Function Tests; Male; Middle Aged

2011
Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Circulation, 2011, Aug-09, Volume: 124, Issue:6

    Topics: Adult; Biomarkers; C-Reactive Protein; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Insulin; Insulin Resistance; Kaplan-Meier Estimate; Male; Metformin; Middle Aged; Myocardial Revascularization; Plasminogen Activator Inhibitor 1; Prognosis; Sulfonylurea Compounds; Thiazolidinediones; Thrombophilia; Tissue Plasminogen Activator

2011
The effects of resistance training on ApoB/ApoA-I ratio, Lp(a) and inflammatory markers in patients with type 2 diabetes.
    Endocrine, 2012, Volume: 42, Issue:3

    Topics: Apolipoprotein A-I; Apolipoproteins B; Biomarkers; Blood Pressure; Body Composition; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Fibrinogen; Glycated Hemoglobin; Humans; Inflammation Mediators; Insulin Resistance; Lipids; Lipoprotein(a); Male; Middle Aged; Resistance Training; Respiratory Function Tests; Waist-Hip Ratio

2012
Investigation of the mechanism(s) involved in decreasing increased fibrinogen activity in hyperglycemic conditions using L-lysine supplementation.
    Thrombosis research, 2012, Volume: 130, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Fibrinogen; Glucose; Humans; Hypoglycemic Agents; Lysine; Male; Middle Aged; Protein Binding; Treatment Outcome

2012
Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial.
    Circulation, 2012, Dec-04, Volume: 126, Issue:23

    Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biomarkers; C-Reactive Protein; Cohort Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibrinogen; Glycated Hemoglobin; Humans; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Lipid Metabolism; Male; Middle Aged; Treatment Outcome; Young Adult

2012
Decreased red blood cell aggregation subsequent to improved glycaemic control in Type 2 diabetes mellitus.
    Diabetic medicine : a journal of the British Diabetic Association, 2003, Volume: 20, Issue:4

    Topics: Adult; Aged; Blood Glucose; Blood Viscosity; Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Male; Middle Aged

2003
Improvement of glycaemic control in type 2 diabetes: favourable changes in blood pressure, total cholesterol and triglycerides, but not in HDL cholesterol, fibrinogen, Von Willebrand factor and (pro)insulin.
    The Netherlands journal of medicine, 2003, Volume: 61, Issue:4

    Topics: Blood Glucose; Blood Pressure; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Proinsulin; Risk Factors; Time Factors; Triglycerides; von Willebrand Factor

2003
Decrease of hemostatic cardiovascular risk factors by aggressive vs. conventional atorvastatin treatment in patients with Type 2 diabetes mellitus.
    Journal of thrombosis and haemostasis : JTH, 2003, Volume: 1, Issue:8

    Topics: Aged; Atorvastatin; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Factor VIIIa; Female; Fibrinogen; Hemostatics; Heptanoic Acids; Humans; Hyperlipidemias; Male; Middle Aged; Placebos; Pyrroles; Risk Factors; Time Factors; Tissue Plasminogen Activator; von Willebrand Factor

2003
[Effect of diet therapy on status of hemocoagulation and fibrinolysis in type 2 diabetes patients].
    Voprosy pitaniia, 2003, Volume: 72, Issue:5

    Topics: Adult; Aged; Blood Coagulation; Blood Pressure; Caloric Restriction; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Lipoproteins, HDL; Male; Malondialdehyde; Middle Aged; Tissue Plasminogen Activator

2003
Effect of metformin on fibrinolytic parameters in insulin-treated, type 2 diabetic patients.
    Diabetes & metabolism, 2003, Volume: 29, Issue:5

    Topics: Aged; Analysis of Variance; Blood Glucose; Cholesterol, LDL; Diabetes Mellitus, Type 2; Fibrinogen; Fibrinolysis; Fructosamine; Humans; Hypoglycemic Agents; Insulin; Metformin; Middle Aged; Plasminogen Activator Inhibitor 1

2003
Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2004, Volume: 36, Issue:1

    Topics: Aged; Arginine; Blood Glucose; Blood Pressure; Body Composition; Body Constitution; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Fibrinogen; Glucose Tolerance Test; Glycated Hemoglobin; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Insulin Resistance; Insulin-Like Growth Factor I; Lipids; Male; Metabolic Syndrome; Metformin; Middle Aged; Obesity; Placebos; Testosterone

2004
Effects of a 12-month physical activity counselling intervention on glycaemic control and on the status of cardiovascular risk factors in people with Type 2 diabetes.
    Diabetologia, 2004, Volume: 47, Issue:5

    Topics: Blood Pressure; Cardiovascular Diseases; Counseling; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Exercise; Fibrinogen; Follow-Up Studies; Humans; Oxygen Consumption; Risk Factors; Time Factors

2004
Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus.
    Journal of hypertension, 2005, Volume: 23, Issue:2

    Topics: Adult; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Enalapril; Female; Fibrinogen; Humans; Hypertension; Intercellular Adhesion Molecule-1; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Tetrazoles; Vascular Cell Adhesion Molecule-1; von Willebrand Factor

2005
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 45, Issue:3

    Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Fenofibrate; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Homocysteine; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Incidence; Male; Middle Aged; Models, Biological; Smoking; Treatment Outcome

2005
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome.
    Pharmacotherapy, 2005, Volume: 25, Issue:5

    Topics: Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinogen; Fibrinolytic Agents; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metabolic Syndrome; Metformin; Middle Aged; Plasminogen Activator Inhibitor 1; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Tissue Plasminogen Activator

2005
Intense cholesterol lowering therapy with a HMG-CoA reductase inhibitor does not improve nitric oxide dependent endothelial function in type-2-diabetes--a multicenter, randomised, double-blind, three-arm placebo-controlled clinical trial.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2005, Volume: 113, Issue:6

    Topics: Blood Glucose; Blood Pressure; Brachial Artery; C-Reactive Protein; Cholesterol; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Female; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Nitric Oxide; Pyridines; Triglycerides; Ultrasonography; Vasodilation

2005
The effect of low-dose atorvastatin on circulating monocyte chemoattractant protein-1 in patients with type 2 diabetes complicated by hyperlipidemia.
    Metabolism: clinical and experimental, 2005, Volume: 54, Issue:9

    Topics: Adult; Aged; Atorvastatin; C-Reactive Protein; Chemokine CCL2; Diabetes Mellitus, Type 2; Female; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Inflammation; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Pyrroles

2005
The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension. An open-label observational study.
    Metabolism: clinical and experimental, 2005, Volume: 54, Issue:9

    Topics: Aged; Arteriosclerosis; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Hypoglycemic Agents; Lipoprotein(a); Male; Middle Aged; Risk Factors; Risk Reduction Behavior; Rosiglitazone; Thiazolidinediones

2005
Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish Diabetes Prevention Study.
    Diabetologia, 2005, Volume: 48, Issue:11

    Topics: Adult; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet; Exercise; Female; Fibrinogen; Fibrinolysis; Finland; Follow-Up Studies; Glucose Intolerance; Humans; Life Style; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Weight Loss

2005
The effect of glycaemic control on fibrin network structure of type 2 diabetic subjects.
    Thrombosis and haemostasis, 2006, Volume: 96, Issue:5

    Topics: Adult; Aged; Blood Coagulation; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fibrin; Fibrinogen; Glycosylation; Humans; Insulin; Male; Middle Aged; Porosity

2006
Decrease in inflammatory cardiovascular risk markers in hyperlipidemic diabetic patients treated with fenofibrate.
    Annals of clinical and laboratory science, 2007,Spring, Volume: 37, Issue:2

    Topics: Atherosclerosis; Biomarkers; Blood Sedimentation; C-Reactive Protein; Cholesterol; Diabetes Mellitus, Type 2; Fenofibrate; Fibrinogen; Humans; Hyperlipidemias; Hypolipidemic Agents; Outpatients; Proinsulin; Risk Factors; Triglycerides

2007
Relaxin expression correlates significantly with serum fibrinogen variation in response to antidiabetic treatment in women with type 2 diabetes mellitus.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2007, Volume: 23, Issue:6

    Topics: Administration, Oral; Adult; Aged; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Hypoglycemic Agents; Male; Middle Aged; Nephelometry and Turbidimetry; Pioglitazone; Relaxin; Sex Factors; Sulfonylurea Compounds; Thiazolidinediones

2007
Improved metabolic control by Ipomoea batatas (Caiapo) is associated with increased adiponectin and decreased fibrinogen levels in type 2 diabetic subjects.
    Diabetes, obesity & metabolism, 2008, Volume: 10, Issue:7

    Topics: Adiponectin; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Ipomoea batatas; Male; Middle Aged; Phytotherapy

2008
Decrease in von Willebrand factor levels after a high-monounsaturated-fat diet in non-insulin-dependent diabetic subjects.
    Metabolism: clinical and experimental, 1994, Volume: 43, Issue:11

    Topics: alpha-Macroglobulins; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dietary Carbohydrates; Dietary Fats, Unsaturated; Endothelium, Vascular; Fatty Acids, Monounsaturated; Female; Fibrinogen; Fibronectins; Humans; Male; Middle Aged; von Willebrand Factor

1994
Plasma levels of von Willebrand factor in non-insulin-dependent diabetes mellitus are influenced by dietary monounsaturated fatty acids.
    Thrombosis research, 1995, Feb-15, Volume: 77, Issue:4

    Topics: alpha-Macroglobulins; Cross-Over Studies; Diabetes Mellitus, Type 2; Diet, Diabetic; Dietary Fats; Dietary Fats, Unsaturated; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Female; Fibrinogen; Fibronectins; Humans; Male; Middle Aged; Olive Oil; Plant Oils; von Willebrand Factor

1995
Physical activity and fibrinogen concentration in newly diagnosed NIDDM.
    Diabetes care, 1994, Volume: 17, Issue:9

    Topics: Adult; Body Mass Index; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Energy Metabolism; Exercise; Fatty Acids; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Regression Analysis; Smoking; Time Factors

1994
Comparison of bezafibrate and simvastatin in the treatment of dyslipidaemia in patients with NIDDM.
    Diabetic medicine : a journal of the British Diabetic Association, 1997, Volume: 14, Issue:7

    Topics: Aged; Apolipoproteins; Bezafibrate; Creatine Kinase; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged; Patient Compliance; Simvastatin

1997
Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.
    Diabetes care, 1998, Volume: 21, Issue:4

    Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Follow-Up Studies; Fosinopril; Glycated Hemoglobin; Humans; Hypertension; Lipids; Male; Middle Aged; Prospective Studies; Time Factors

1998
Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study.
    Diabetes care, 1998, Volume: 21, Issue:4

    Topics: Adult; Aged; Bezafibrate; Carotid Arteries; Cholesterol; Cholesterol, HDL; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Electrocardiography; Exercise Test; Female; Femoral Artery; Fibrinogen; Follow-Up Studies; Humans; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Middle Aged; Placebos; Time Factors; Triglycerides; Ultrasonography

1998
[Coefficient of linear correlation between levels of fibrinogen, antithrombin III, thrombin-antithrombin complex and lipid fractions in women exposed chronically to carbon disulfide].
    Medycyna pracy, 1998, Volume: 49, Issue:1

    Topics: Adult; Antithrombin III; Blood Coagulation; Carbon Disulfide; Diabetes Mellitus, Type 2; Environmental Exposure; Environmental Monitoring; Female; Fibrinogen; Humans; Linear Models; Lipids; Middle Aged; Occupational Exposure; Risk Factors

1998
A randomised, controlled study of the effects of aerobic exercise and dietary fish on coagulation and fibrinolytic factors in type 2 diabetics.
    Thrombosis and haemostasis, 1999, Volume: 81, Issue:3

    Topics: Adult; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Exercise; Factor VII; Female; Fibrinogen; Fibrinolysis; Fish Products; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator

1999
Metabolic effects of temocapril in hypertensive patients with diabetes mellitus type 2.
    Journal of cardiovascular pharmacology, 1999, Volume: 33, Issue:4

    Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Carbohydrate Metabolism; Diabetes Mellitus, Type 2; Double-Blind Method; Enalapril; Female; Fibrinogen; Humans; Hypertension; Kidney Function Tests; Lipoproteins; Male; Middle Aged; Patient Compliance; Prospective Studies; Thiazepines

1999
Repaglinide versus glyburide: a one-year comparison trial.
    Diabetes research and clinical practice, 1999, Volume: 43, Issue:3

    Topics: Adult; Aged; Blood Glucose; C-Peptide; Carbamates; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibrinogen; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Piperidines; Prospective Studies; Triglycerides; United States; United States Food and Drug Administration

1999
Will acarbose improve the metabolic abnormalities of insulin-resistant type 2 diabetes mellitus?
    Diabetes research and clinical practice, 1999, Volume: 43, Issue:3

    Topics: Acarbose; Adult; Aged; Area Under Curve; Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Double-Blind Method; Enzyme Inhibitors; Female; Fibrinogen; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Male; Microvascular Angina; Middle Aged; Proinsulin; Random Allocation; Triglycerides; Trisaccharides

1999
Short- and long-term treatments with iloprost in diabetic patients with peripheral vascular disease: effects on the cardiovascular risk factor plasminogen activator inhibitor type-1.
    European journal of clinical pharmacology, 1999, Volume: 55, Issue:7

    Topics: Aged; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fasting; Female; Fibrinogen; Glycated Hemoglobin; Humans; Iloprost; Insulin; Male; Middle Aged; Peripheral Vascular Diseases; Pilot Projects; Plasminogen; Plasminogen Activator Inhibitor 1; Platelet Aggregation Inhibitors; Risk Factors; Time Factors; Treatment Outcome; Walking

1999
High dose supplementation of RRR-alpha-tocopherol decreases cellular hemostasis but accelerates plasmatic coagulation in type 2 diabetes mellitus.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1999, Volume: 31, Issue:12

    Topics: Aged; Antigens, CD; Antioxidants; Arteriosclerosis; Case-Control Studies; Cell Adhesion Molecules; Diabetes Mellitus, Type 2; Female; Fibrinogen; Hemostasis; Humans; Leukocytes; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Platelet Aggregation; Platelet Endothelial Cell Adhesion Molecule-1; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Vitamin E

1999
Ciprofibrate effects on carbohydrate and lipid metabolism in type 2 diabetes mellitus subjects.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2000, Volume: 10, Issue:1

    Topics: Adult; Aged; Apolipoproteins B; Area Under Curve; Arteriosclerosis; Blood Glucose; Carbohydrate Metabolism; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibric Acids; Fibrinogen; Glycated Hemoglobin; Humans; Hypolipidemic Agents; Lipid Metabolism; Lipoprotein(a); Male; Middle Aged; Triglycerides

2000
Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: correlation with plasma glucagon concentrations.
    The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:9

    Topics: Adult; Blood Glucose; Capillaries; Diabetes Mellitus, Type 2; Fibrinogen; Glucagon; Humans; Insulin; Kinetics; Leucine; Lipids; Male; Middle Aged

2000
The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II diabetic subjects.
    Diabetologia, 2000, Volume: 43, Issue:9

    Topics: Acute-Phase Proteins; Albuminuria; Biomarkers; Blood Glucose; C-Reactive Protein; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Endothelium, Vascular; Female; Fibrinogen; Fibronectins; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Interleukin-6; Male; Middle Aged; Sulfonylurea Compounds; Thrombomodulin; Tumor Necrosis Factor-alpha; von Willebrand Factor

2000
Further insight on the hypoglycemic and nonhypoglycemic effects of troglitazone 400 or 600 mg/d: effects on the very-low-density and high-density lipoprotein particle distribution.
    Metabolism: clinical and experimental, 2002, Volume: 51, Issue:1

    Topics: Aged; Blood Glucose; Chromans; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Lipoproteins; Lipoproteins, HDL; Lipoproteins, VLDL; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Thiazoles; Thiazolidinediones; Troglitazone

2002
Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients.
    American journal of hypertension, 2002, Volume: 15, Issue:4 Pt 1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hypertension; Losartan; Male; Middle Aged; Perindopril; Plasminogen Activator Inhibitor 1

2002
Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes.
    Metabolism: clinical and experimental, 2002, Volume: 51, Issue:6

    Topics: Blood Glucose; Blood Pressure; Body Constitution; Body Mass Index; C-Reactive Protein; Causality; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Leukocyte Count; Male; Metabolic Syndrome; Middle Aged; Multivariate Analysis; Risk Factors

2002
Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia.
    Diabetes care, 2002, Volume: 25, Issue:7

    Topics: Adult; Aged; Anticholesteremic Agents; Apolipoproteins; Atorvastatin; Blood Glucose; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fenofibrate; Fibrinogen; Heptanoic Acids; Humans; Hyperlipidemias; Lipoprotein(a); Lipoproteins, HDL; Male; Middle Aged; Pyrroles; Triglycerides

2002
The effect of a slow release formulation of bezafibrate on lipids, glucose homeostasis, platelets and fibrinogen in type II diabetics: a pilot study.
    Diabetes research (Edinburgh, Scotland), 1990, Volume: 14, Issue:3

    Topics: Adenosine Diphosphate; Bezafibrate; Blood Glucose; Blood Platelets; Cholesterol; Collagen; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Fibrinogen; Homeostasis; Humans; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Triglycerides

1990

Other Studies

276 other study(ies) available for fibrinogen and Diabetes Mellitus, Type 2

ArticleYear
The Neoepitopes on Methylglyoxal- (MG-) Glycated Fibrinogen Generate Autoimmune Response: Its Role in Diabetes, Atherosclerosis, and Diabetic Atherosclerosis Subjects.
    Oxidative medicine and cellular longevity, 2021, Volume: 2021

    Topics: Adult; Atherosclerosis; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Middle Aged; Pyruvaldehyde

2021
Biophysical changes in methylglyoxal modified fibrinogen and its role in the immunopathology of type 2 diabetes mellitus.
    International journal of biological macromolecules, 2022, Mar-31, Volume: 202

    Topics: Animals; Diabetes Mellitus, Type 2; Fibrinogen; Glycation End Products, Advanced; Glycosylation; Humans; Immunoglobulin G; Pyruvaldehyde; Rabbits

2022
Association of fibrinogen and plasminogen activator inhibitor-1 with diabetes mellitus.
    Pakistan journal of pharmaceutical sciences, 2022, Volume: 35, Issue:1(Suppleme

    Topics: Adult; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Lipids; Male; Plasminogen Activator Inhibitor 1; Young Adult

2022
High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort.
    Cardiovascular diabetology, 2022, 03-21, Volume: 21, Issue:1

    Topics: Albumins; Cohort Studies; Coronary Artery Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Inflammation; Male; Percutaneous Coronary Intervention; Risk Factors; Stroke; Time Factors; Treatment Outcome

2022
Estimation of Serum Fibrinogen in Males with Type 2 Diabetes.
    Mymensingh medical journal : MMJ, 2022, Volume: 31, Issue:2

    Topics: Adult; Bangladesh; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Male; Middle Aged

2022
Fibrinogen Levels in Type 2 Diabetes Mellitus and it's Correlation with Microvascular Microvascular Complications.
    The Journal of the Association of Physicians of India, 2022, Volume: 70, Issue:4

    Topics: Albumins; Albuminuria; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hyperglycemia; Male

2022
Hemorheological and microvascular disturbances in patients with type 2 diabetes mellitus.
    Clinical hemorheology and microcirculation, 2022, Volume: 81, Issue:4

    Topics: Blood Viscosity; Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Erythrocyte Deformability; Fibrinogen; Hematocrit; Hemorheology; Humans; Microcirculation

2022
Predictive significance of joint plasma fibrinogen and urinary alpha-1 microglobulin-creatinine ratio in patients with diabetic kidney disease.
    PloS one, 2022, Volume: 17, Issue:7

    Topics: Biomarkers; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fibrinogen; Humans; Retrospective Studies

2022
Associations of Nutritional, Environmental, and Metabolic Biomarkers with Diabetes-Related Mortality in U.S. Adults: The Third National Health and Nutrition Examination Surveys between 1988-1994 and 2016.
    Nutrients, 2022, Jun-24, Volume: 14, Issue:13

    Topics: Adult; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Middle Aged; Nutrition Surveys; Thyrotropin

2022
Immunoglobulin G N-glycan, inflammation and type 2 diabetes in East Asian and European populations: a Mendelian randomization study.
    Molecular medicine (Cambridge, Mass.), 2022, 09-14, Volume: 28, Issue:1

    Topics: C-Reactive Protein; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Immunoglobulin G; Inflammation; Mendelian Randomization Analysis; Polysaccharides

2022
Elimination of fibrin polymer formation or crosslinking, but not fibrinogen deficiency, is protective against diet-induced obesity and associated pathologies.
    Journal of thrombosis and haemostasis : JTH, 2022, Volume: 20, Issue:12

    Topics: Afibrinogenemia; Animals; Diabetes Mellitus, Type 2; Diet; Factor XIII; Fibrin; Fibrinogen; Hemostatics; Mice; Non-alcoholic Fatty Liver Disease; Obesity; Polymers

2022
Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system.
    Cardiovascular diabetology, 2022, 09-21, Volume: 21, Issue:1

    Topics: alpha-2-Antiplasmin; Biomarkers; C-Reactive Protein; COVID-19; Diabetes Mellitus, Type 2; Fibrin; Fibrinogen; Humans; Interleukin-6; Plasma Kallikrein; Platelet Factor 4; Post-Acute COVID-19 Syndrome; Proteomics; Thrombosis; von Willebrand Factor

2022
Consumption of Plant Foods and Its Association with Cardiovascular Disease Risk Profile in South Africans at High-Risk of Type 2 Diabetes Mellitus.
    International journal of environmental research and public health, 2022, 10-14, Volume: 19, Issue:20

    Topics: Cardiovascular Diseases; Cholesterol, LDL; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Insulins; Male; Middle Aged; Obesity; Risk Factors; South Africa; Triglycerides; Vitamin A

2022
The predictive value of fibrinogen in the occurrence of mild cognitive impairment events in patients with diabetic peripheral neuropathy.
    BMC endocrine disorders, 2022, Nov-02, Volume: 22, Issue:1

    Topics: Cognitive Dysfunction; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Fibrinogen; Humans; Risk Factors

2022
Role of Fibrinogen in Type-2 Diabetes Mellitus with Diabetic Neuropathy and its Preliminary Mechanism.
    Protein and peptide letters, 2023, Volume: 30, Issue:6

    Topics: Animals; Constriction, Pathologic; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Fibrinogen; Male; Rats; Rats, Sprague-Dawley

2023
Comparative proteomics of proliferative diabetic retinopathy in people with Type 2 diabetes highlights the role of inflammation, visual transduction, and extracellular matrix pathways.
    Indian journal of ophthalmology, 2023, Volume: 71, Issue:8

    Topics: Diabetes Mellitus, Type 2; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix; Fibrinogen; Humans; Inflammation; Proteome; Proteomics; Vision, Ocular

2023
Mild cognitive impairment in type 2 diabetes is associated with fibrinogen-to-albumin ratios.
    PeerJ, 2023, Volume: 11

    Topics: Adult; Albumins; Cognitive Dysfunction; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Middle Aged; Retrospective Studies

2023
A low-cost laboratory-based method for predicting newly diagnosed biopsy-proven diabetic nephropathy in people with type 2 diabetes.
    Diabetic medicine : a journal of the British Diabetic Association, 2020, Volume: 37, Issue:10

    Topics: Aged; Biopsy; Blood Cell Count; Blood Chemical Analysis; Blood Coagulation Tests; Blood Glucose; Blood Pressure; Body Mass Index; China; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Glycated Hemoglobin; Humans; Kidney; Male; Middle Aged; Multivariate Analysis; Partial Thromboplastin Time; Prognosis; Risk Assessment; Thrombin Time

2020
Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson's disease patients with type 2 diabetes mellitus.
    Aging, 2020, 08-15, Volume: 12, Issue:15

    Topics: Age Factors; Aged; Biomarkers; Blood Glucose; China; Cholesterol, LDL; Dementia; Diabetes Mellitus, Type 2; Female; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Inflammation; Male; Middle Aged; Parkinson Disease; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Vascular Diseases

2020
Quantifying Fibrinogen-Dependent Aggregation of Red Blood Cells in Type 2 Diabetes Mellitus.
    Biophysical journal, 2020, 09-01, Volume: 119, Issue:5

    Topics: Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Erythrocytes; Fibrinogen; Humans; Optical Tweezers

2020
Relation Between Globulin, Fibrinogen, and Albumin With the Presence and Severity of Coronary Artery Disease.
    Angiology, 2021, Volume: 72, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glomerular Filtration Rate; Humans; Male; Middle Aged; Risk Factors; Triglycerides

2021
Depression as a risk factor for dementia in older people with type 2 diabetes and the mediating effect of inflammation.
    Diabetologia, 2021, Volume: 64, Issue:2

    Topics: Aged; C-Reactive Protein; Dementia; Depressive Disorder; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Mediation Analysis; Middle Aged; Proportional Hazards Models; Risk Factors; Tumor Necrosis Factor-alpha

2021
Involvement of Essential Signaling Cascades and Analysis of Gene Networks in Diabesity.
    Genes, 2020, 10-25, Volume: 11, Issue:11

    Topics: Adipocytes; Angiotensinogen; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fibrinogen; Gene Regulatory Networks; Lipolysis; Obesity; Oxidative Stress; Receptor, IGF Type 1; Receptors, LDL; Renin; Shc Signaling Adaptor Proteins

2020
Glycation and acetylation sites on fibrinogen in plasma fibrin clot of patients with type 2 diabetes: Effects of low-dose acetylsalicylic acid.
    Thrombosis research, 2021, Volume: 198

    Topics: Acetylation; Aspirin; Diabetes Mellitus, Type 2; Fibrin; Fibrinogen; Fibrinolysis; Humans; Proteomics

2021
[Vascular damage-related risk factors for erectile dysfunction in patients with type 2 diabetes mellitus: Analysis based on a nomogram model].
    Zhonghua nan ke xue = National journal of andrology, 2020, Volume: 26, Issue:5

    Topics: Carotid Intima-Media Thickness; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Erectile Dysfunction; Erythrocyte Indices; Fibrinogen; Humans; Male; Nomograms; Risk Factors

2020
Methylglyoxal mediated glycation leads to neo-epitopes generation in fibrinogen: Role in the induction of adaptive immune response.
    International journal of biological macromolecules, 2021, Apr-01, Volume: 175

    Topics: Adaptive Immunity; Animals; Autoantibodies; Cross Reactions; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Epitopes; Female; Fibrinogen; Glycation End Products, Advanced; Glycosylation; Hyperglycemia; Immune Sera; Immunoglobulin G; Pyruvaldehyde; Rabbits

2021
The Use of Machine Learning Techniques to Determine the Predictive Value of Inflammatory Biomarkers in the Development of Type 2 Diabetes Mellitus.
    Metabolic syndrome and related disorders, 2021, Volume: 19, Issue:4

    Topics: Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Inflammation; Insulin Resistance; Machine Learning; Predictive Value of Tests; Retrospective Studies

2021
Clinical and predictive significance of Plasma Fibrinogen Concentrations combined Monocyte-lymphocyte ratio in patients with Diabetic Retinopathy.
    International journal of medical sciences, 2021, Volume: 18, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Female; Fibrinogen; Humans; Leukocyte Count; Lymphocytes; Male; Middle Aged; Monocytes; Predictive Value of Tests; Prognosis; Risk Assessment

2021
Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity.
    Acta diabetologica, 2017, Volume: 54, Issue:8

    Topics: Adult; Aged; Blood Glucose; Blood Pressure; Blood Viscosity; Diabetes Mellitus, Type 2; Fasting; Female; Fibrinogen; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin Resistance; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Risk Factors; Triglycerides

2017
Influence of type 2 diabetes mellitus on Khorana venous thromboembolism risk in colorectal cancer patients.
    Revista espanola de enfermedades digestivas, 2017, Volume: 109, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; China; Colorectal Neoplasms; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Middle Aged; Risk; Risk Assessment; Venous Thromboembolism

2017
Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study.
    BMJ open, 2017, 06-09, Volume: 7, Issue:6

    Topics: Aged; Beijing; C-Reactive Protein; Comorbidity; Coronary Artery Bypass; Coronary Artery Disease; Death; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Stroke; Stroke Volume

2017
Importance of inflammatory markers and IL-6 for diagnosis and follow up of patients with type 2 diabetes mellitus.
    Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina, 2017, Aug-01, Volume: 14, Issue:2

    Topics: Adult; Biomarkers; C-Reactive Protein; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose; Glycated Hemoglobin; Humans; Inflammation; Interleukin-6; Leukocyte Count; Male; Middle Aged

2017
Bone Mineral Density in Relation to Metabolic Syndrome Components in Postmenopausal Women With Diabetes Mellitus Type 2
    Acta clinica Croatica, 2017, Volume: 56, Issue:1

    Topics: Aged; Biomarkers; Body Mass Index; Bone Density; C-Reactive Protein; Collagen; Diabetes Mellitus, Type 2; Female; Femur; Fibrinogen; Glycated Hemoglobin; Humans; Hyperinsulinism; Insulin; Metabolic Syndrome; Middle Aged; Obesity; Obesity, Abdominal; Osteocalcin; Osteoporosis, Postmenopausal; Peptide Fragments; Plasminogen Activator Inhibitor 1; Postmenopause; Spine; Waist Circumference

2017
Serum fibrinogen predicts diabetic ESRD in patients with type 2 diabetes mellitus.
    Diabetes research and clinical practice, 2018, Volume: 141

    Topics: Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Fibrinogen; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Retrospective Studies

2018
Overexpression of Hepassocin in Diabetic Patients with Nonalcoholic Fatty Liver Disease May Facilitate Increased Hepatic Lipid Accumulation.
    Endocrine, metabolic & immune disorders drug targets, 2019, Volume: 19, Issue:2

    Topics: Adult; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Fatty Liver; Female; Fibrinogen; Humans; Insulin; Lipid Metabolism; Liver; Male; Neoplasm Proteins; Non-alcoholic Fatty Liver Disease; Up-Regulation

2019
Hyperfibrinogenemia in Peripheral Arterial Disease: Coexistent and Independent Risk Factor (A Report of Two Cases and Review of Literature).
    Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki), 2018, Dec-01, Volume: 39, Issue:2-3

    Topics: Amputation, Surgical; Anticholesteremic Agents; Atorvastatin; Diabetes Mellitus, Type 2; Fenofibrate; Fibrinogen; Humans; Hypolipidemic Agents; Intermittent Claudication; Ischemia; Lower Extremity; Male; Middle Aged; Peripheral Arterial Disease; Predictive Value of Tests; Risk Factors; Treatment Outcome

2018
The additive effect of type 2 diabetes on fibrinogen, von Willebrand factor, tryptophan and threonine in people living with HIV.
    Amino acids, 2019, Volume: 51, Issue:5

    Topics: Biomarkers; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; HIV; HIV Infections; Humans; Male; Middle Aged; Risk Factors; Threonine; Tryptophan; von Willebrand Factor

2019
Inverse association between habitual alcohol drinking and d-dimer in patients with type 2 diabetes mellitus.
    Alcohol (Fayetteville, N.Y.), 2020, Volume: 83

    Topics: Aged; Aged, 80 and over; Alcohol Drinking; Blood Coagulation; Body Mass Index; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Glycated Hemoglobin; Humans; Male; Middle Aged; Risk Factors; Smoking

2020
Evaluation of platelet reactivity during combined antiplatelet therapy in patients with stable coronary artery disease in relation to diabetes type 2 and the GPIIB/IIIA receptor gene polymorphism.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2019, Volume: 70, Issue:2

    Topics: Blood Platelets; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Integrin beta3; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Prospective Studies; Thromboxane B2

2019
Role of relationship between HbA1c, fibrinogen and HDL-cholesterol on cardiovascular disease in patients with type 2 diabetes mellitus.
    Atherosclerosis, 2013, Volume: 228, Issue:1

    Topics: Aged; Atherosclerosis; Cardiovascular Diseases; Cholesterol, HDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Risk Factors

2013
Association of the -262C/T polymorphism in the catalase gene promoter and the C242T polymorphism of the NADPH oxidase P22phox gene with essential arterial hypertension in patients with diabetes mellitus type 2.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2014, Volume: 36, Issue:1

    Topics: Aged; C-Reactive Protein; Case-Control Studies; Catalase; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Genetic Predisposition to Disease; Glutathione Peroxidase; Humans; Hypertension; Male; Middle Aged; NADPH Oxidases; Oxidative Stress; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Risk Factors; Slovenia

2014
Association of PAI-1 and fibrinogen with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT).
    Diabetes care, 2014, Volume: 37, Issue:2

    Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fibrinogen; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prospective Studies; Veterans

2014
Fruits and vegetables diet improves some selected haemorheological parameters predisposing to cardiovascular disease in non insulin dependent diabetes mellitus NIDDM subjects.
    Pakistan journal of biological sciences : PJBS, 2012, Jul-15, Volume: 15, Issue:14

    Topics: Blood Sedimentation; Blood Viscosity; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus, Type 2; Diet; Fibrinogen; Fruit; Hematocrit; Hemorheology; Humans; Nigeria; Risk Factors; Vegetables

2012
Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE study.
    Diabetes, 2014, Volume: 63, Issue:3

    Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Interleukin-6; Male; Middle Aged; Risk Factors

2014
Association of activated partial thromboplastin time and fibrinogen level in patients with type II diabetes mellitus.
    BMC research notes, 2013, Nov-25, Volume: 6

    Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Hospitals, Teaching; Humans; Hypoglycemic Agents; Male; Middle Aged; Nepal; Partial Thromboplastin Time; Tertiary Healthcare

2013
Analysis of a sample of type 2 diabetic patients with obesity or overweight and at cardiovascular risk: a cross sectional study in Spain.
    BMC research notes, 2014, Jan-21, Volume: 7

    Topics: Age of Onset; Anthropometry; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diet; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hypertension; Insulin; Life Style; Lipids; Male; Middle Aged; Motor Activity; Obesity; Overweight; Risk Factors; Spain

2014
Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile.
    Acta diabetologica, 2014, Volume: 51, Issue:6

    Topics: Adult; Aged; Asymptomatic Diseases; Blood Glucose; Blood Sedimentation; C-Reactive Protein; Cardiovascular Diseases; Chronic Disease; Complement C3; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Humans; Inflammation; Male; Metabolome; Middle Aged; Prediabetic State; Risk Factors; Time Factors

2014
Proinflammatory and prothrombotic state in subjects with different glucose tolerance status before cardiovascular disease.
    Journal of diabetes research, 2014, Volume: 2014

    Topics: Adult; Aged; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Early Diagnosis; Female; Fibrinogen; Glucose Intolerance; Glycated Hemoglobin; Humans; Male; Mexico; Middle Aged; Overweight; Prediabetic State; Risk Factors; Thrombosis; Vasculitis

2014
Association of fibrinogen with severity of stable coronary artery disease in patients with type 2 diabetic mellitus.
    Disease markers, 2014, Volume: 2014

    Topics: Adult; Aged; Angina, Stable; Area Under Curve; Biomarkers; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; ROC Curve; Severity of Illness Index

2014
Relation of asymmetric dimethylarginine levels to macrovascular disease and inflammation markers in type 2 diabetic patients.
    Journal of diabetes research, 2014, Volume: 2014

    Topics: Aged; Arginine; Atherosclerosis; Biomarkers; Blood Sedimentation; C-Reactive Protein; Carotid Intima-Media Thickness; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Homocysteine; Humans; Inflammation Mediators; Male; Middle Aged; Regression Analysis; Systemic Vasculitis; Up-Regulation

2014
Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3.
    Diabetologia, 2014, Volume: 57, Issue:8

    Topics: Aged; C-Reactive Protein; Complement C3; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysis; Humans; Inflammation; Male; Middle Aged; Plasminogen Activator Inhibitor 1

2014
Inflammation and glycemic tolerance status in pregnancy: the role of maternal adiposity.
    Gynecologic and obstetric investigation, 2014, Volume: 78, Issue:1

    Topics: Adiposity; Blood Glucose; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Ferritins; Fibrinogen; Glucose Intolerance; Glucose Tolerance Test; Humans; Inflammation; Insulin Resistance; Interleukin-6; Leukocyte Count; Obesity; Pregnancy; Risk Factors

2014
Associations between ambient air pollution and blood markers of inflammation and coagulation/fibrinolysis in susceptible populations.
    Environment international, 2014, Volume: 70

    Topics: Adult; Aged; Air Pollutants; Air Pollution; Biomarkers; Blood Coagulation; C-Reactive Protein; CD40 Antigens; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysis; Germany; Glutathione Transferase; Humans; Inflammation; Male; Middle Aged; Particulate Matter; Peroxidase; Polymorphism, Single Nucleotide

2014
[Determination of efficacy of second application of Urokinase Medac in a diabetic foot syndrome].
    Klinichna khirurhiia, 2014, Issue:3

    Topics: Blood Gas Monitoring, Transcutaneous; Diabetes Mellitus, Type 2; Diabetic Foot; Drug Administration Schedule; Fibrinogen; Humans; Ischemia; Leg; Re-Epithelialization; Treatment Outcome; Urokinase-Type Plasminogen Activator

2014
The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease.
    Thrombosis and haemostasis, 2014, Volume: 112, Issue:6

    Topics: Aged; Aspirin; Blood Coagulation Tests; C-Reactive Protein; Case-Control Studies; Complement C3; Coronary Artery Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Inflammation Mediators; Male; Microscopy, Confocal; Microscopy, Electron, Scanning; Middle Aged; Nephelometry and Turbidimetry; Platelet Aggregation Inhibitors; Registries; Risk Factors; Sex Factors; Time Factors

2014
Unfavorable inflammatory profile in adults at risk of type 2 diabetes identified by hemoglobin A1c levels according to the American Diabetes Association criteria.
    Acta diabetologica, 2015, Volume: 52, Issue:2

    Topics: Adult; Aged; American Medical Association; Association; Biomarkers; Blood Glucose; Blood Sedimentation; C-Reactive Protein; Complement C3; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Male; Middle Aged; Prediabetic State; United States

2015
Clinical utility of the ratio between circulating fibrinogen and fibrin (ogen) degradation products for evaluating coronary artery disease in type 2 diabetic patients.
    Chinese medical journal, 2015, Mar-20, Volume: 128, Issue:6

    Topics: Aged; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Fibrin; Fibrinogen; Humans; Male; Middle Aged

2015
Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics.
    Cardiovascular diabetology, 2015, Mar-08, Volume: 14

    Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Erythrocytes; Female; Fibrinogen; Humans; Male; Middle Aged; Random Allocation; Thrombin

2015
Higher plasma betatrophin/ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistance.
    Scientific reports, 2015, Jun-16, Volume: 5

    Topics: Adult; Age Factors; Aged; Angiopoietin-Like Protein 8; Angiopoietin-like Proteins; Blood Glucose; Body Mass Index; Case-Control Studies; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Male; Middle Aged; Peptide Hormones; Risk Factors; Waist-Hip Ratio

2015
Association of subclinical inflammation with deterioration of glycaemia before the diagnosis of type 2 diabetes: the KORA S4/F4 study.
    Diabetologia, 2015, Volume: 58, Issue:10

    Topics: Acute-Phase Proteins; Adiponectin; Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Prospective Studies; Serum Amyloid A Protein

2015
Hemorheological Approach for Early Detection of Chronic Kidney Disease and Diabetic Nephropathy in Type 2 Diabetes.
    Diabetes technology & therapeutics, 2015, Volume: 17, Issue:11

    Topics: Albuminuria; Biomarkers; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Early Diagnosis; Erythrocyte Aggregation; Erythrocyte Deformability; Fasting; Female; Fibrinogen; Glomerular Filtration Rate; Humans; Male; Middle Aged; Regression Analysis; Renal Insufficiency, Chronic

2015
Plasma levels of thrombomodulin, plasminogen activator inhibitor-1 and fibrinogen in elderly, diabetic patients with depressive symptoms.
    Aging clinical and experimental research, 2016, Volume: 28, Issue:5

    Topics: Aged; Biomarkers; Cholesterol, LDL; Depression; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Neuropsychological Tests; Plasminogen Activator Inhibitor 1; Prospective Studies; Risk Factors; Statistics as Topic; Thrombomodulin

2016
Effects of Endovascular Interventions on vWF and Fb Levels in Type 2 Diabetic Patients with Peripheral Artery Disease.
    Annals of vascular surgery, 2016, Volume: 33

    Topics: Aged; Angioplasty, Balloon; Biomarkers; Blood Coagulation; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Male; Peripheral Arterial Disease; Prothrombin Time; Stents; Time Factors; Treatment Outcome; Up-Regulation; von Willebrand Factor

2016
Correlation between the plasma fibrinogen concentration and coronary heart disease severity in Moroccan patients with type 2 diabetes. Prospective study.
    Annales d'endocrinologie, 2016, Volume: 77, Issue:5

    Topics: Aged; Aged, 80 and over; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Male; Middle Aged; Morocco; Prospective Studies; Risk Factors; Severity of Illness Index

2016
A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes.
    Diabetologia, 2016, Volume: 59, Issue:8

    Topics: Aged; Animals; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Intolerance; Hep G2 Cells; Humans; Insulin; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Middle Aged; Neoplasm Proteins

2016
Association of novel metrics of particulate matter with vascular markers of inflammation and coagulation in susceptible populations -results from a panel study.
    Environmental research, 2016, Volume: 150

    Topics: Aged; Air Pollutants; Blood Coagulation; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Intolerance; Glutathione Transferase; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Particulate Matter; Peroxidase; Polymorphism, Single Nucleotide

2016
Correlation of Oxidative Stress Parameters and Inflammatory Markers in Ischemic Stroke Patients.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2016, Volume: 25, Issue:11

    Topics: Aged; Biomarkers; Blood Glucose; Brain Ischemia; C-Reactive Protein; Diabetes Mellitus, Type 2; Erythrocytes; Female; Fibrinogen; Glutathione Peroxidase; Glycated Hemoglobin; Humans; Inflammation Mediators; Lipids; Male; Middle Aged; Oxidative Stress; Predictive Value of Tests; Prognosis; Stroke; Superoxide Dismutase

2016
Influence of glyco-oxidation on complexes between fibrin(ogen) and insulin-like growth factor-binding protein-1 in patients with diabetes mellitus type 2.
    Free radical research, 2017, Volume: 51, Issue:1

    Topics: Aged; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Insulin-Like Growth Factor Binding Protein 1; Male; Middle Aged; Oxidation-Reduction; Protein Binding

2017
BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.
    Thrombosis and haemostasis, 2017, 01-26, Volume: 117, Issue:2

    Topics: Aged; Blood Coagulation Tests; Diabetes Mellitus, Type 2; Female; Fibrin; Fibrinogen; Fibrinolysis; Genetic Association Studies; Genotype; Humans; Male; Microscopy, Electron, Scanning; Middle Aged; Phenotype; Polymorphism, Genetic; Protein Conformation; Risk Assessment; Risk Factors; Scotland; Structure-Activity Relationship; Thrombosis

2017
Predictive value of non-fasting remnant cholesterol for short-term outcome of diabetics with new-onset stable coronary artery disease.
    Lipids in health and disease, 2017, Jan-13, Volume: 16, Issue:1

    Topics: Aged; Biomarkers; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clopidogrel; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neutrophils; Prognosis; Proportional Hazards Models; ROC Curve; Ticlopidine; Treatment Outcome

2017
CRP and fibrinogen imply clinical outcome of patients with Type-2 diabetes and coronary artery disease.
    Acta biochimica et biophysica Sinica, 2017, 03-01, Volume: 49, Issue:3

    Topics: Angina Pectoris; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Inflammation; Prognosis; Prospective Studies

2017
Intensification of oxidative stress and inflammation in type 2 diabetes despite antihyperglycemic treatment.
    Cardiovascular diabetology, 2008, Jun-22, Volume: 7

    Topics: Adult; Aged; Apoptosis; C-Reactive Protein; Case-Control Studies; CD11b Antigen; Diabetes Mellitus, Type 2; Fibrinogen; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Insulin; Leukocytes, Mononuclear; Metformin; Middle Aged; Oxidative Stress; Rosiglitazone; Superoxides; Thiazolidinediones; Transferrin

2008
Thrombolytic-associated coagulopathy and management dilemmas: a review of two cases.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2008, Volume: 19, Issue:6

    Topics: Aged; Aged, 80 and over; Case Management; Cerebral Hemorrhage; Diabetes Mellitus, Type 2; Factor VIII; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Infarction, Middle Cerebral Artery; International Normalized Ratio; Intubation, Intratracheal; Partial Thromboplastin Time; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator

2008
Association between serum lipoprotein (a) level and progression of non-proliferative diabetic retinopathy in Type 2 diabetes.
    Acta ophthalmologica, 2009, Volume: 87, Issue:5

    Topics: Aged; Asian People; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Fundus Oculi; Glycated Hemoglobin; Humans; Lipoprotein(a); Male; Middle Aged; Predictive Value of Tests; Risk Assessment; Systole; Time Factors

2009
Relation of cardiorespiratory fitness to inflammatory markers, fibrinolytic factors, and lipoprotein(a) in patients with type 2 diabetes mellitus.
    The American journal of cardiology, 2008, Sep-15, Volume: 102, Issue:6

    Topics: Age Factors; Biomarkers; Body Fat Distribution; C-Reactive Protein; Cardiovascular Physiological Phenomena; Cholesterol; Diabetes Mellitus, Type 2; Exercise Test; Fibrinogen; Humans; Leukocyte Count; Lipoprotein(a); Male; Middle Aged; Oxygen Consumption; Physical Fitness; Plasminogen Activator Inhibitor 1; Respiratory Physiological Phenomena; Tissue Plasminogen Activator

2008
The association of plasma fibrinogen concentration with diabetic microvascular complications in young adults with early-onset of type 2 diabetes.
    Diabetes research and clinical practice, 2008, Volume: 82, Issue:3

    Topics: Adult; Albumins; Biomarkers; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Fibrinogen; Humans; Indians, North American; Inflammation; Microcirculation

2008
Food intake patterns associated with incident type 2 diabetes: the Insulin Resistance Atherosclerosis Study.
    Diabetes care, 2009, Volume: 32, Issue:2

    Topics: Adult; Aged; Biomarkers; Blood Glucose; Cohort Studies; Diabetes Mellitus, Type 2; Energy Intake; Feeding Behavior; Female; Fibrinogen; Follow-Up Studies; Glucose Tolerance Test; Humans; Incidence; Inflammation; Insulin; Insulin Resistance; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Regression Analysis; Risk Factors; Surveys and Questionnaires

2009
Serological evidence of infections and Type 2 diabetes: the MultiEthnic Study of Atherosclerosis.
    Diabetic medicine : a journal of the British Diabetic Association, 2009, Volume: 26, Issue:2

    Topics: Aged; Aged, 80 and over; C-Reactive Protein; Chlamydophila Infections; Chlamydophila pneumoniae; Cross-Sectional Studies; Cytomegalovirus; Cytomegalovirus Infections; Diabetes Mellitus, Type 2; Female; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Hepatitis A; Hepatitis A Virus, Human; Herpes Simplex; Humans; Immunoglobulin G; Interleukin-6; Male; Middle Aged; Risk Factors; Seroepidemiologic Studies; Simplexvirus; United States

2009
NASH and cardiovascular biomarkers.
    Obesity (Silver Spring, Md.), 2009, Volume: 17, Issue:4

    Topics: Adiponectin; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fatty Liver; Fibrinogen; Humans; Intra-Abdominal Fat; Obesity; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Triglycerides

2009
Adiponectin has different mechanisms in type 1 and type 2 diabetes with C-peptide link.
    Clinical and investigative medicine. Medecine clinique et experimentale, 2009, Aug-01, Volume: 32, Issue:4

    Topics: Adiponectin; Adult; C-Peptide; C-Reactive Protein; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Humans; Middle Aged; Triglycerides; Uric Acid

2009
Fibrinogen is associated with silent myocardial ischaemia in type 2 diabetes mellitus.
    Acta cardiologica, 2009, Volume: 64, Issue:4

    Topics: Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Ischemia

2009
Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients.
    Cardiovascular diabetology, 2009, Sep-07, Volume: 8

    Topics: Acute Coronary Syndrome; Angina Pectoris; Blood Viscosity; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Fibrinogen; Fibrinolysis; Follow-Up Studies; Hemorheology; Humans; Hypercholesterolemia; Incidence; Myocardial Infarction; Myocardial Revascularization; Plasminogen Inactivators; Risk Factors; Thrombophilia

2009
[Assessment of the level of homocysteine and the state of haemostasis in patients with and without type 2 diabetes mellitus in remote terms after reconstructive operations on the aorto-iliac segment].
    Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery, 2009, Volume: 15, Issue:2

    Topics: Aged; Antithrombin III; Aorta, Abdominal; Blood Vessel Prosthesis Implantation; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Homocysteine; Humans; Iliac Artery; Leg; Male; Middle Aged; Plastic Surgery Procedures; Platelet Aggregation; Postoperative Complications; Thromboplastin; Time Factors

2009
Increased ceruloplasmin and fibrinogen in type 2 diabetes corresponds to decreased anti-oxidant activity in a preliminary tertiary South Indian hospital study.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2010, Volume: 118, Issue:1

    Topics: Adult; Aged; Aging; Alcohol Drinking; Antioxidants; Ceruloplasmin; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; India; Inflammation; Male; Middle Aged; Oxidative Stress; Pilot Projects; Sex Characteristics; Smoking; Young Adult

2010
Air temperature and inflammatory and coagulation responses in men with coronary or pulmonary disease during the winter season.
    Occupational and environmental medicine, 2010, Volume: 67, Issue:6

    Topics: Aged; Biomarkers; Blood Coagulation; C-Reactive Protein; Coronary Disease; Diabetes Mellitus, Type 2; Fibrinogen; Germany; Health Status Indicators; Humans; Lung Diseases; Male; Middle Aged; Risk Factors; Seasons; Temperature

2010
Effect of periodontal treatment on metabolic control, systemic inflammation and cytokines in patients with type 2 diabetes.
    Journal of clinical periodontology, 2010, Volume: 37, Issue:1

    Topics: Adult; Blood Glucose; C-Reactive Protein; Chronic Periodontitis; Cytokines; Dental Plaque Index; Dental Scaling; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Gingival Hemorrhage; Glycated Hemoglobin; Humans; Inflammation Mediators; Interleukin-10; Interleukin-4; Interleukin-6; Interleukin-8; Male; Middle Aged; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Root Planing; Tumor Necrosis Factor-alpha

2010
Clinical implications of adiponectin and inflammatory biomarkers in type 2 diabetes mellitus.
    Disease markers, 2009, Volume: 27, Issue:6

    Topics: Adiponectin; Adult; Aged; Aged, 80 and over; Biomarkers; Body Mass Index; C-Reactive Protein; Cohort Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Inflammation; Kidney; Lasers, Gas; Lipids; Male; Middle Aged; Risk Factors; Sensitivity and Specificity; Vascular Diseases

2009
Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Diabetes care, 2010, Volume: 33, Issue:4

    Topics: Aged; Aged, 80 and over; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Incidence; Inflammation; Interleukin-6; Male; Middle Aged; United States

2010
Inadequate glucose control in type 2 diabetes is associated with impaired lung function and systemic inflammation: a cross-sectional study.
    BMC pulmonary medicine, 2010, Jul-26, Volume: 10

    Topics: Adult; Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Ferritins; Fibrinogen; Glycated Hemoglobin; Humans; Hyperglycemia; Inflammation; Interleukin-6; Lung Diseases; Male; Middle Aged; Respiratory Function Tests; Tumor Necrosis Factor-alpha

2010
Expression and significance of fgl2 prothrombinase in cardiac microvascular endothelial cells of rats with type 2 diabetes.
    Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2010, Volume: 30, Issue:5

    Topics: Animals; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endothelial Cells; Fibrinogen; Male; Microvessels; Myocardial Ischemia; Rats; Rats, Sprague-Dawley; Thromboplastin; Thrombosis; Tumor Necrosis Factor-alpha

2010
Coagulation profile in diabetes and its association with diabetic microvascular complications.
    The Journal of the Association of Physicians of India, 2010, Volume: 58

    Topics: Adult; Age Factors; Aged; Blood Coagulation Factors; Blood Coagulation Tests; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Diabetic Retinopathy; Endothelium, Vascular; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1

2010
Genetic associations between fibrinogen and cognitive performance in three Scottish cohorts.
    Behavior genetics, 2011, Volume: 41, Issue:5

    Topics: Aged; Aging; Aspirin; Atherosclerosis; Cognition; Cognition Disorders; Cohort Studies; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Fibrinogen; Genotype; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Scotland

2011
Proteinuria in a patient with diabetes.
    Kidney international, 2011, Volume: 79, Issue:7

    Topics: Amyloidosis, Familial; Biopsy; Diabetes Mellitus, Type 2; DNA Mutational Analysis; Fibrinogen; Humans; Kidney Diseases; Kidney Glomerulus; Male; Middle Aged; Mutation; Proteinuria

2011
Microvascular complications and risk factors in patients with type 2 diabetes.
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2011, Volume: 58, Issue:4

    Topics: Aged; Albuminuria; Anthropometry; Antihypertensive Agents; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Habits; Humans; Hypoglycemic Agents; Lipids; Male; Microcirculation; Middle Aged; Prospective Studies; Risk Factors

2011
[Peripheral blood indicators of inflammatory response during the first twenty-four hours of ischemic stroke].
    Annales Academiae Medicae Stetinensis, 2010, Volume: 56, Issue:1

    Topics: Aged; Biomarkers; Brain Ischemia; C-Reactive Protein; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Fibrinogen; Humans; Hypertension; Inflammation Mediators; Leukocyte Count; Male; Stroke; Tumor Necrosis Factor-alpha

2010
Correlations between abdominal circumference and the breakage resistance of the fibrin clot in patients with diabetes mellitus type 2.
    Romanian journal of internal medicine = Revue roumaine de medecine interne, 2010, Volume: 48, Issue:2

    Topics: Aged; Brain Ischemia; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Obesity, Abdominal; Platelet Activation; Thrombophilia; Thrombosis; Time; Waist Circumference

2010
The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2011, Volume: 22, Issue:6

    Topics: Aged; Albuminuria; Blood Coagulation; Blood Pressure; Body Mass Index; Carboxypeptidase B2; Case-Control Studies; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hypertension; Male; Middle Aged; Peptide Fragments; Plasminogen Activator Inhibitor 1; Prothrombin; Sex Factors; Slovakia; Thrombin; Tissue Plasminogen Activator

2011
Deficiency of mast cells in coronary artery endarterectomy of male patients with type 2 diabetes.
    Cardiovascular diabetology, 2011, May-14, Volume: 10

    Topics: Aged; Coronary Artery Bypass; Coronary Artery Disease; Coronary Vessels; Diabetes Mellitus, Type 2; Endarterectomy; Fibrin; Fibrinogen; Fluorescent Antibody Technique; Humans; Hypertension; Immunoglobulin G; Male; Mast Cells; Middle Aged; Pilot Projects; Slovenia; Staining and Labeling

2011
Elevated plasma factor VIII and von Willebrand factor in women with type 2 diabetes: inflammatory reaction, endothelial perturbation or else?
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2011, Volume: 22, Issue:7

    Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Carotid Intima-Media Thickness; Diabetes Mellitus, Type 2; Endothelium, Vascular; Factor VIII; Female; Fibrinogen; Humans; Inflammation; Middle Aged; Thrombomodulin; Tunica Intima; Ultrasonography, Doppler, Color; von Willebrand Factor

2011
Spontaneous platelet aggregation evaluated by laser light scatter in patients with type 2 diabetes: effects of short-term improved glycemic control and adiponectin.
    Translational research : the journal of laboratory and clinical medicine, 2012, Volume: 159, Issue:1

    Topics: Adiponectin; Adult; Aged; Area Under Curve; Blood Glucose; Blood Platelets; C-Reactive Protein; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemic Agents; Lasers; Male; Metformin; Middle Aged; Platelet Aggregation; Platelet Count; Scattering, Radiation; Serum Albumin; Sulfonylurea Compounds

2012
Remodelling of biological parameters during human ageing: evidence for complex regulation in longevity and in type 2 diabetes.
    Age (Dordrecht, Netherlands), 2013, Volume: 35, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Analysis of Variance; Biomarkers; Blood Glucose; C-Reactive Protein; Chi-Square Distribution; Cholesterol; Diabetes Mellitus, Type 2; Factor Analysis, Statistical; Female; Fibrinogen; Hematologic Tests; Hemoglobins; Humans; Italy; Leukocyte Count; Longevity; Male; Middle Aged; Principal Component Analysis; Triglycerides

2013
Hemorheology and vascular reactivity in patients with diabetes mellitus type 2.
    Clinical hemorheology and microcirculation, 2011, Volume: 49, Issue:1-4

    Topics: Adult; Aged; Blood Flow Velocity; Body Mass Index; Cerebrovascular Circulation; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Erythrocyte Indices; Female; Fibrinogen; Hemorheology; Humans; Lipids; Male; Middle Aged; Middle Cerebral Artery; Posture; Skin; Toes; Ultrasonography

2011
Hemorheology and heart rate variability in patients with diabetes mellitus type 2.
    Clinical hemorheology and microcirculation, 2011, Volume: 49, Issue:1-4

    Topics: Adult; Aged; Blood Flow Velocity; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Female; Fibrinogen; Fourier Analysis; Glycated Hemoglobin; Heart Rate; Hemorheology; Humans; Lipids; Male; Middle Aged; Posture; Rest; Stress, Mechanical

2011
Association of Helicobacter pylori infection with microalbuminuria in type 2 diabetic patients.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2011, Volume: 22, Issue:6

    Topics: Adult; Aged; Albuminuria; Blood Sedimentation; C-Reactive Protein; Case-Control Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Leukocyte Count; Lipoprotein(a); Logistic Models; Male; Middle Aged; Platelet Count; Statistics, Nonparametric

2011
Diabetic fatty liver disease is associated with specific changes in blood-borne markers.
    Diabetes/metabolism research and reviews, 2012, Volume: 28, Issue:4

    Topics: Adiponectin; Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Biomarkers; Cholesterol; Collagen Type I; Diabetes Mellitus, Type 2; Fatty Liver; Female; Fibrinogen; Humans; Hyaluronic Acid; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Peptides; Triglycerides

2012
[Hyperhomocysteinemia and plasma acute-phase proteins in patients with type 2 diabetes mellitus and severe course of atherosclerosis after vascular operations].
    Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery, 2011, Volume: 17, Issue:4

    Topics: Atherosclerosis; C-Reactive Protein; Diabetes Mellitus, Type 2; Disease Progression; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Male; Middle Aged; Postoperative Complications; Risk Assessment; Severity of Illness Index; Statistics as Topic; Vascular Surgical Procedures

2011
Short-term effects of air temperature on blood markers of coagulation and inflammation in potentially susceptible individuals.
    Occupational and environmental medicine, 2012, Volume: 69, Issue:9

    Topics: Adult; Aged; Air; Biomarkers; Blood Coagulation; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Exercise; Female; Fibrinogen; Germany; Glucose Intolerance; Glucose Metabolism Disorders; Humans; Inflammation; Inflammation Mediators; Interleukin-5; Male; Middle Aged; Obesity; Plasminogen; Polymorphism, Genetic; Prospective Studies; Sex Factors; Temperature; Time Factors

2012
Patients with prostate cancer treated by ADT have significantly higher fibrinogenemia than healthy control.
    World journal of urology, 2013, Volume: 31, Issue:2

    Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Fibrinogen; Gonadotropin-Releasing Hormone; Humans; Insulin Resistance; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Testosterone; Triglycerides

2013
Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.
    American journal of respiratory and critical care medicine, 2012, Nov-15, Volume: 186, Issue:10

    Topics: Aged; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Forced Expiratory Volume; Heart Failure; Humans; Inflammation Mediators; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Pneumonia; Pulmonary Disease, Chronic Obstructive; Risk; Vital Capacity

2012
Association of optimism with cardiometabolic risk in adolescents.
    The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2013, Volume: 52, Issue:4

    Topics: Biomarkers; Black or African American; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Character; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Insulin; Interleukin-6; Lipids; Massachusetts; Motivation; Personality Inventory; Puberty; Risk Factors; Smoking; White People

2013
Influence of fibrinogen and C-RP on progression of peripheral arterial disease in type 2 diabetes: a preliminary report.
    Cardiovascular diabetology, 2013, Feb-01, Volume: 12

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cohort Studies; Diabetes Mellitus, Type 2; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Peripheral Arterial Disease; Prospective Studies

2013
Obesity, coronary heart disease risk factors and diabetes in Chinese: an approach to the criteria of obesity in the Chinese population.
    Obesity reviews : an official journal of the International Association for the Study of Obesity, 2002, Volume: 3, Issue:3

    Topics: Adult; Aged; Anthropometry; Asian People; Blood Glucose; Blood Pressure; China; Cholesterol, HDL; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hypertension; Hypertriglyceridemia; Male; Middle Aged; Obesity; Prevalence; Prospective Studies; Risk Factors; Sex Distribution; Triglycerides

2002
Insulin resistance is accompanied by increased von Willebrand factor levels in nondiabetic women: a study of offspring of type 2 diabetic subjects compared to offspring of nondiabetic subjects.
    Journal of internal medicine, 2002, Volume: 252, Issue:2

    Topics: Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibronectins; Humans; Insulin Resistance; Logistic Models; Male; Middle Aged; von Willebrand Factor

2002
Leukocyte count and fibrinogen are associated with carotid and femoral intima-media thickness in a risk population for diabetes.
    Cardiovascular research, 2002, Volume: 56, Issue:2

    Topics: Adult; Aged; Analysis of Variance; Arteriosclerosis; Carotid Artery, Common; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Femoral Artery; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Risk Factors; Tunica Intima; Tunica Media

2002
Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk.
    The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:11

    Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Arteriosclerosis; Blood Glucose; Blood Pressure; Body Constitution; Body Mass Index; Cardiovascular Diseases; Carotid Arteries; Cholesterol; Cushing Syndrome; Diabetes Mellitus, Type 2; Diastole; Fasting; Female; Fibrinogen; Glucose Intolerance; Humans; Hyperlipidemias; Hypertension; Insulin; Insulin Resistance; Male; Middle Aged; Risk Factors; Systole; Triglycerides; Ultrasonography

2002
Relation of serum sialic acid to blood coagulation activity in type 2 diabetes.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2002, Volume: 13, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Biomarkers; Blood Coagulation; Cohort Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Japan; Male; Middle Aged; N-Acetylneuraminic Acid; Platelet Count; Risk Factors

2002
Sensitivity of the ultrasonic interferometry method (Echo-Cell) to changes of red cell aggregation: application to diabetes.
    Clinical hemorheology and microcirculation, 2002, Volume: 27, Issue:3-4

    Topics: Adult; Biophysical Phenomena; Biophysics; Blood Sedimentation; Dextrans; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Equipment Design; Erythrocyte Aggregation; Erythrocytes; Female; Fibrinogen; Hemorheology; Humans; Interferometry; Male; Middle Aged; Sensitivity and Specificity; Ultrasonics; Ultrasonography

2002
C-reactive protein and insulin resistance in non-obese Japanese type 2 diabetic patients.
    Metabolism: clinical and experimental, 2002, Volume: 51, Issue:12

    Topics: Asian People; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Homeostasis; Humans; Insulin Resistance; Japan; Lipids; Male; Middle Aged; Thinness

2002
Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients.
    Arteriosclerosis, thrombosis, and vascular biology, 2003, Jun-01, Volume: 23, Issue:6

    Topics: Adult; Blood Glucose; Body Mass Index; C-Reactive Protein; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Gastroplasty; Humans; Inflammation; Insulin; Insulin Resistance; Interleukin-6; Lipids; Longitudinal Studies; Male; Middle Aged; Obesity, Morbid; Tumor Necrosis Factor-alpha; Weight Loss

2003
Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.
    Diabetes, 2003, Volume: 52, Issue:5

    Topics: Adiponectin; Adipose Tissue; Adult; Blood Glucose; Blood Pressure; Body Constitution; C-Reactive Protein; Diabetes Mellitus, Type 2; Family; Fasting; Fibrinogen; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Proinsulin; Proteins; Reference Values

2003
Insulin acutely increases fibrinogen production in individuals with type 2 diabetes but not in individuals without diabetes.
    Diabetes, 2003, Volume: 52, Issue:7

    Topics: Amino Acids; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Fibrinogen; Glucagon; Humans; Insulin; Male; Middle Aged; Reference Values; Triglycerides

2003
Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study.
    Diabetes care, 2003, Volume: 26, Issue:7

    Topics: Aged; Albuminuria; Apolipoproteins B; Biomarkers; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypertension; Male; Patient Selection; Prospective Studies; Regression Analysis; Risk Factors; Smoking; Time Factors

2003
Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study.
    Diabetes care, 2003, Volume: 26, Issue:10

    Topics: Aged; Albuminuria; Arteriosclerosis; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hypertrophy, Left Ventricular; Incidence; Indians, North American; Inflammation; Male; Middle Aged; Prevalence; Risk Factors; Thrombosis

2003
Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion.
    Circulation, 2003, Oct-14, Volume: 108, Issue:15

    Topics: Adipose Tissue; Arteriosclerosis; Body Composition; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Disease Susceptibility; Female; Fibrinogen; Follow-Up Studies; Glucose Tolerance Test; Humans; Incidence; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prediabetic State; Risk Factors

2003
Insulin resistance, hemostatic factors, and hormone interactions in pre- and perimenopausal women: SWAN.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:10

    Topics: Adult; Climacteric; Diabetes Mellitus, Type 2; Estradiol; Factor VII; Female; Fibrinogen; Follicle Stimulating Hormone; Hemostasis; Humans; Insulin Resistance; Middle Aged; Plasminogen Activator Inhibitor 1; Premenopause; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Tissue Plasminogen Activator

2003
Plasma interleukin-6 is associated with coagulation in poorly controlled patients with Type 2 diabetes.
    Diabetic medicine : a journal of the British Diabetic Association, 2003, Volume: 20, Issue:11

    Topics: Blood Coagulation; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hospitalization; Humans; Insulin; Interleukin-6; Male; Middle Aged; Sulfonylurea Compounds

2003
Increase in hepatic mRNA expression of coagulant factors in type 2 diabetic model mice.
    Thrombosis research, 2003, Volume: 111, Issue:1-2

    Topics: Animals; Blood Coagulation Factors; Diabetes Mellitus, Type 2; Disease Models, Animal; DNA, Complementary; Fibrinogen; Mice; Mice, Mutant Strains; Prothrombin; Reference Values; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic

2003
Angiotensin-converting enzyme genotype, albuminuria and plasma fibrinogen in type 2 diabetes mellitus.
    Wiener klinische Wochenschrift, 2003, Dec-15, Volume: 115, Issue:23

    Topics: Aged; Albuminuria; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Female; Fibrinogen; Genotype; Glycated Hemoglobin; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Perindopril; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors; Smoking

2003
[Effect of danshen injection on expression of platelet membrane glycoproteins in patients with type II diabetes mellitus].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2003, Volume: 26, Issue:10

    Topics: Adult; Aged; Blood Platelets; Child, Preschool; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Female; Fibrinogen; Flow Cytometry; Humans; Male; Middle Aged; P-Selectin; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Salvia miltiorrhiza

2003
Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome.
    Heart (British Cardiac Society), 2004, Volume: 90, Issue:3

    Topics: Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Leukocyte Count; Male; Multivariate Analysis; Myocardial Infarction; Prognosis; Spain; Survival Analysis

2004
[Homocysteine and C-reactive protein concentrations in serum of diabetic patients].
    Przeglad lekarski, 2003, Volume: 60, Issue:12

    Topics: Aged; Blood Glucose; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Lipids; Male; Middle Aged; Sex Factors; Triglycerides

2003
Augmentation of inhibitory effects of glycoprotein IIb-IIIa antagonists in patients with diabetes.
    Thrombosis research, 2004, Volume: 113, Issue:1

    Topics: Abciximab; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Blood Platelets; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycosylation; Humans; Immunoglobulin Fab Fragments; Kinetics; Male; Membrane Proteins; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Time Factors

2004
Urinary albumin excretion is correlated to fibrinogen levels and protein S activity in patients with type 1 diabetes mellitus without overt diabetic nephropathy.
    Wiener klinische Wochenschrift, 2004, Apr-30, Volume: 116, Issue:7-8

    Topics: Adult; Age Factors; Albuminuria; Blood Coagulation Tests; Body Mass Index; Data Interpretation, Statistical; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fibrinogen; Humans; Male; Middle Aged; Protein S; Sex Factors

2004
Results of blood inflammatory markers are associated more strongly with toe-brachial index than with ankle-brachial index in patients with type 2 diabetes.
    Diabetes care, 2004, Volume: 27, Issue:6

    Topics: Aged; Ankle Joint; Biomarkers; Blood Flow Velocity; Brachial Artery; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Functional Laterality; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Plethysmography; Regression Analysis; Reproducibility of Results; Toes

2004
Initiation of insulin therapy reduces serum concentrations of high-sensitivity C-reactive protein in patients with type 2 diabetes.
    Metabolism: clinical and experimental, 2004, Volume: 53, Issue:6

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Body Constitution; Body Weight; C-Reactive Protein; Chemokine CCL2; Diabetes Mellitus, Type 2; Fasting; Female; Fibrinogen; Humans; Injections, Subcutaneous; Insulin; Male; Middle Aged; Regression Analysis; Smoking; Time Factors

2004
Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes.
    Diabetes care, 2004, Volume: 27, Issue:7

    Topics: Adiponectin; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Inflammation; Intercellular Signaling Peptides and Proteins; Life Style; Lipids; Male; Receptors, Tumor Necrosis Factor, Type II; Statistics, Nonparametric

2004
Blood rheology in patients with diabetes mellitus.
    Clinical hemorheology and microcirculation, 2004, Volume: 30, Issue:3-4

    Topics: Adult; Blood Glucose; Blood Viscosity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Erythrocyte Aggregation; Female; Fibrinogen; Glycated Hemoglobin; Hemorheology; Humans; Male; Middle Aged

2004
Acute-phase proteins and microalbuminuria among patients with type 2 diabetes.
    Diabetes research and clinical practice, 2004, Volume: 66, Issue:1

    Topics: Acute-Phase Proteins; Age of Onset; Albuminuria; Blood Proteins; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fibrinogen; Humans; Male; Middle Aged; Orosomucoid; Reference Values; Regression Analysis

2004
Abnormal glucose tolerance--a common risk factor in patients with acute myocardial infarction in comparison with population-based controls.
    Journal of internal medicine, 2004, Volume: 256, Issue:4

    Topics: Acute Disease; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypertension; Insulin Resistance; Lipids; Male; Myocardial Infarction; Proinsulin; Prospective Studies; Risk Factors; Triglycerides

2004
Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia.
    Clinica chimica acta; international journal of clinical chemistry, 2004, Volume: 348, Issue:1-2

    Topics: Albuminuria; alpha-2-Antiplasmin; Biomarkers; Blood Coagulation; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Interleukin-6; Linear Models; Male; Middle Aged; Protein C

2004
Rheological changes in diabetic microangiopathy.
    Romanian journal of internal medicine = Revue roumaine de medecine interne, 2004, Volume: 42, Issue:2

    Topics: Biomarkers; Blood Glucose; Blood Platelets; Blood Viscosity; Cell Adhesion; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Male; Middle Aged

2004
Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range.
    European heart journal, 2004, Volume: 25, Issue:23

    Topics: Aged; Biomarkers; Blood Glucose; Blood Sedimentation; Body Mass Index; C-Reactive Protein; Coronary Artery Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Leukocyte Count; Male; Middle Aged; Reference Values

2004
Factors related to exercise capacity in asymptomatic middle-aged type 2 diabetic patients.
    Diabetes research and clinical practice, 2005, Volume: 67, Issue:2

    Topics: Adult; Coronary Disease; Diabetes Mellitus, Type 2; Electrocardiography; Exercise; Exercise Test; Fasting; Female; Fibrinogen; Heart Rate; Homeostasis; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Prospective Studies; Sex Characteristics; Smoking

2005
Levels of plasma fibrinogen and d-dimer in patients with impaired fasting glucose.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2005, Volume: 113, Issue:1

    Topics: Adult; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Fasting; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged

2005
Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study.
    Diabetologia, 2005, Volume: 48, Issue:3

    Topics: Aged; Albuminuria; Biomarkers; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinogen; Follow-Up Studies; Humans; Italy; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Regression Analysis; Risk; Time Factors

2005
The -455G/A polymorphism of the beta fibrinogen gene and the Bgl II polymorphism of the alpha2beta1 integrin gene and myocardial infarction in patients with type 2 diabetes.
    Folia biologica, 2004, Volume: 50, Issue:6

    Topics: Bacterial Proteins; Deoxyribonucleases, Type II Site-Specific; Diabetes Mellitus, Type 2; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Integrin alpha2beta1; Male; Myocardial Infarction; Polymorphism, Genetic; White People

2004
[Relation between diabetes compensation, albuminuria and biochemical parameters and the results of stress myocardial SPECT in asymptomatic type 2 diabetics].
    Vnitrni lekarstvi, 2004, Volume: 50, Issue:12

    Topics: Albuminuria; C-Reactive Protein; Coronary Circulation; Coronary Disease; Diabetes Mellitus, Type 2; Exercise Test; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Tomography, Emission-Computed, Single-Photon; Uric Acid

2004
Contribution of abdominal visceral obesity and insulin resistance to the cardiovascular risk profile of postmenopausal women.
    Diabetes, 2005, Volume: 54, Issue:3

    Topics: Adipose Tissue; Aged; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Insulin Resistance; Interleukin-6; Lipids; Middle Aged; Obesity; Postmenopause; Risk

2005
The K469E polymorphism of the intercellular adhesion molecule-1 gene is associated with plasma fibrinogen level in type 2 diabetes.
    Metabolism: clinical and experimental, 2005, Volume: 54, Issue:3

    Topics: Albuminuria; Blood Pressure; Carotid Arteries; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Exons; Female; Femoral Artery; Fibrinogen; Genotype; Humans; Insulin Resistance; Intercellular Adhesion Molecule-1; Male; Middle Aged; Polymorphism, Genetic; Regression Analysis; Ultrasonography

2005
Relationship among urinary albumin excretion rate, lipoprotein lipase PvuII polymorphism and plasma fibrinogen in type 2 diabetic patients.
    Physiological research, 2006, Volume: 55, Issue:1

    Topics: Albuminuria; Diabetes Mellitus, Type 2; Female; Fibrinogen; Genotype; Humans; Linear Models; Lipoprotein Lipase; Male; Middle Aged; Polymorphism, Genetic

2006
The influence of type 2 diabetes on fibrin structure and function.
    Diabetologia, 2005, Volume: 48, Issue:6

    Topics: Blood Coagulation; Body Mass Index; Body Size; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Factor XIII; Female; Fibrin; Fibrinogen; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Reference Values; Risk Factors

2005
Insulin sensitivity and fibrinogen concentrations in normoglycaemic offspring of Type 2 diabetic parents.
    Diabetic medicine : a journal of the British Diabetic Association, 2005, Volume: 22, Issue:8

    Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged

2005
Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program.
    Diabetes care, 2005, Volume: 28, Issue:10

    Topics: C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Intolerance; Homeostasis; Humans; Lipoproteins; Male; Middle Aged; Regression Analysis; Risk Factors; Tissue Plasminogen Activator; Triglycerides

2005
Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM.
    International journal of cardiology, 2006, Jan-04, Volume: 106, Issue:1

    Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cerebrovascular Disorders; Chi-Square Distribution; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Prevalence; Risk Factors

2006
Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease.
    Journal of clinical pathology, 2006, Volume: 59, Issue:2

    Topics: Aged; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Interleukin-6; Male; Middle Aged; Peripheral Vascular Diseases; Polymorphism, Genetic; Vascular Endothelial Growth Factor A

2006
Albumin and fibrinogen synthesis and insulin effect in type 2 diabetic patients with normoalbuminuria.
    Diabetes care, 2006, Volume: 29, Issue:2

    Topics: Adult; Case-Control Studies; Diabetes Mellitus, Type 2; Fibrinogen; Glucagon; Humans; Hypertension; Hypoglycemic Agents; Insulin; Leucine; Male; Serum Albumin

2006
The role of inflammation in diabetes and its complications.
    Southern medical journal, 2006, Volume: 99, Issue:1

    Topics: Atherosclerosis; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Inflammation; Interleukins; Risk Factors; Serum Amyloid A Protein

2006
Correlation of high-sensitivity C-reactive protein and plasma fibrinogen with individual complications in patients with type 2 diabetes.
    Southern medical journal, 2006, Volume: 99, Issue:1

    Topics: Biomarkers; C-Reactive Protein; Carotid Artery, Common; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Electrocardiography; Female; Fibrinogen; Humans; Male; Middle Aged; Sensitivity and Specificity; Severity of Illness Index; Tunica Intima; Ultrasonography

2006
Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus.
    Diabetologia, 2006, Volume: 49, Issue:5

    Topics: Aged; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Drug Resistance; Enzyme Activation; Factor XIII; Female; Fibrin; Fibrinogen; Fibrinolysin; Glycated Hemoglobin; Hemolysis; Humans; Male; Mass Spectrometry; Middle Aged; Reference Values; Surface Plasmon Resonance

2006
Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.
    Circulation, 2006, Apr-11, Volume: 113, Issue:14

    Topics: Adult; Aged; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Progression; Female; Fibrinogen; Glucose Tolerance Test; Humans; Incidence; Male; Middle Aged; Plasminogen Activator Inhibitor 1

2006
[The meaning of the combination of fibrinogen, micro/macroalbuminuria and atheromatosis in the carotid bloodstream for the evaluation of the abnormal finding of the stress myocardial SPECT in the asymptomatic 2nd type diabetic patients].
    Vnitrni lekarstvi, 2006, Volume: 52, Issue:2

    Topics: Albuminuria; Atherosclerosis; Carotid Arteries; Carotid Artery Diseases; Coronary Circulation; Coronary Disease; Diabetes Mellitus, Type 2; Dipyridamole; Female; Fibrinogen; Heart Ventricles; Humans; Male; Middle Aged; Tomography, Emission-Computed, Single-Photon; Ultrasonography

2006
Diabetic nephropathy is associated with increased albumin and fibrinogen production in patients with type 2 diabetes.
    Diabetologia, 2006, Volume: 49, Issue:8

    Topics: Albuminuria; C-Reactive Protein; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fibrinogen; Humans; Middle Aged; Serum Albumin

2006
Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.
    Diabetes, 2006, Volume: 55, Issue:8

    Topics: Adiposity; Blood Glucose; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Fasting; Female; Fibrinogen; Fibrinolysis; Glycated Hemoglobin; Homeostasis; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1

2006
Low-grade systemic inflammation and the risk of type 2 diabetes in obese children and adolescents.
    Neuro endocrinology letters, 2006, Volume: 27, Issue:4

    Topics: Adolescent; Biomarkers; Blood Glucose; C-Reactive Protein; Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Inflammation; Insulin; Interleukin-1beta; Interleukin-6; Leukocyte Count; Male; Obesity; Risk Factors; Triglycerides

2006
Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with newly diagnosed hypertension or type II diabetes.
    Archives of medical research, 2006, Volume: 37, Issue:8

    Topics: C-Reactive Protein; Carotid Arteries; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Hypertension; Tunica Media

2006
Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients.
    Clinical endocrinology, 2006, Volume: 65, Issue:5

    Topics: Age Factors; Atherosclerosis; Calcifediol; Carotid Artery, Common; Case-Control Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Middle Aged; Prevalence; Regression Analysis; Risk Factors; Sex Factors; Smoking; Tunica Media; Ultrasonography; Vitamin D Deficiency

2006
Vascular phenotype and subclinical inflammation in diabetic Asian Indians without overt cardiovascular disease.
    Diabetes research and clinical practice, 2007, Volume: 76, Issue:3

    Topics: Adult; Aged; Anthropometry; Asian People; C-Reactive Protein; Cardiovascular Diseases; Carotid Arteries; Diabetes Mellitus, Type 2; Electrocardiography; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Netherlands; Phenotype; Suriname

2007
Glycation of fibrinogen in uncontrolled diabetic patients and the effects of glycaemic control on fibrinogen glycation.
    Thrombosis research, 2007, Volume: 120, Issue:3

    Topics: Adult; Black People; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Glycosylation; Humans; Insulin; Male; Middle Aged

2007
[Postprandial glycemia in diabetes patients: assessing this indicator].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:12 Pt 1

    Topics: Administration, Inhalation; Administration, Oral; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Postprandial Period; Pregnancy; Pregnancy in Diabetics; Risk Factors; Time Factors; Tumor Necrosis Factor-alpha

2006
Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2008, Volume: 18, Issue:1

    Topics: Aged; Atherosclerosis; Biomarkers; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Italy; Male; Metabolic Syndrome; Middle Aged; Odds Ratio; Prevalence; Risk Assessment; Risk Factors; Serum Albumin; Uric Acid

2008
Non-traditional cardiovascular risk factors contribute to peripheral arterial disease in patients with type 2 diabetes.
    Diabetes research and clinical practice, 2007, Volume: 78, Issue:2

    Topics: Aged; Ankle; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Italy; Logistic Models; Male; Middle Aged; Peripheral Vascular Diseases; Prevalence; Pulse; Risk Factors; Smoking

2007
[Metabolic syndrome and plasma fibrinogen in type 2 diabetic patients].
    Medicinski arhiv, 2007, Volume: 61, Issue:1

    Topics: Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Lipids; Male; Metabolic Syndrome; Middle Aged

2007
PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes.
    Diabetes/metabolism research and reviews, 2008, Volume: 24, Issue:2

    Topics: Aged; Apolipoproteins B; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hyperinsulinism; Intra-Abdominal Fat; Lipoproteins, LDL; Male; Middle Aged; Particle Size; Phenotype; Plasminogen Activator Inhibitor 1; Tomography, X-Ray Computed; von Willebrand Factor

2008
Endothelial dysfunction correlates with plasma fibrinogen and HDL cholesterol in type 2 diabetic patients with coronary artery disease.
    Bratislavske lekarske listy, 2007, Volume: 108, Issue:7

    Topics: Cholesterol, HDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Fibrinogen; Humans; Middle Aged

2007
[Adiponectinemia, inflammatory process activity, and endothelial dysfunction in patients with type 2 diabetes and acute coronary syndrome with ST elevation in relation to the severity of lesions in the coronary arteries].
    Polskie Archiwum Medycyny Wewnetrznej, 2007, Volume: 117, Issue:8

    Topics: Acute Coronary Syndrome; Adiponectin; Aged; Angioplasty, Balloon, Coronary; Atherosclerosis; Biomarkers; C-Reactive Protein; Case-Control Studies; Creatine Kinase, MB Form; Diabetes Mellitus, Type 2; Endothelial Cells; Female; Fibrinogen; Humans; Inflammation; Intercellular Adhesion Molecule-1; Male; Middle Aged; Severity of Illness Index; Troponin T; Vascular Cell Adhesion Molecule-1

2007
Effects of dietary protein restriction on albumin and fibrinogen synthesis in macroalbuminuric type 2 diabetic patients.
    Diabetologia, 2008, Volume: 51, Issue:1

    Topics: Adult; Albumins; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet, Protein-Restricted; Dietary Proteins; Female; Fibrinogen; Humans; Leucine; Male; Middle Aged; Proteinuria; Treatment Outcome

2008
Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes.
    The aging male : the official journal of the International Society for the Study of the Aging Male, 2007, Volume: 10, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Comorbidity; Diabetes Mellitus, Type 2; Fibrinogen; Glycated Hemoglobin; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Prostatic Neoplasms; Retrospective Studies; Risk Factors; Triglycerides

2007
Relation of plasma homocysteine levels to atherosclerotic vascular disease and inflammation markers in type 2 diabetic patients.
    European journal of endocrinology, 2008, Volume: 158, Issue:1

    Topics: Aged; Atherosclerosis; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Fibrinogen; Homocysteine; Humans; Inflammation; Interleukin-6; Kidney Function Tests; Middle Aged; Tumor Necrosis Factor-alpha

2008
Inflammatory markers, insulin resistance and carotid intima-media thickness in North-Indian type 2 diabetic subjects.
    The Journal of the Association of Physicians of India, 2007, Volume: 55

    Topics: Age Factors; Biomarkers; C-Reactive Protein; Carotid Arteries; Carotid Artery Diseases; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; India; Inflammation; Insulin Resistance; Male; Middle Aged; Prospective Studies; Risk Factors; Tumor Necrosis Factor-alpha

2007
The impact of metabolic syndrome and CRP on vascular phenotype in type 2 diabetes mellitus.
    European journal of internal medicine, 2008, Volume: 19, Issue:2

    Topics: Aged; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; E-Selectin; Female; Fibrinogen; Humans; Inflammation; Male; Metabolic Syndrome; Middle Aged; Phenotype; Plasminogen Activator Inhibitor 1; Thrombomodulin; Tissue Plasminogen Activator; Tunica Intima; Tunica Media; Vascular Cell Adhesion Molecule-1; von Willebrand Factor

2008
The markers of inflammation and endothelial dysfunction in correlation with glycated haemoglobin are present in type 2 diabetes mellitus patients but not in their relatives.
    Glycoconjugate journal, 2008, Volume: 25, Issue:6

    Topics: Adult; Biomarkers; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; E-Selectin; Endothelium, Vascular; Female; Fibrinogen; Glycated Hemoglobin; Hemodynamics; Humans; Inflammation; Insulin; Intercellular Adhesion Molecule-1; Male; Middle Aged; Vascular Cell Adhesion Molecule-1

2008
Glycaemic control improves fibrin network characteristics in type 2 diabetes - a purified fibrinogen model.
    Thrombosis and haemostasis, 2008, Volume: 99, Issue:4

    Topics: Adult; Aged; Blood Glucose; Case-Control Studies; Cross-Linking Reagents; Diabetes Mellitus, Type 2; Elasticity; Factor XIIIa; Female; Fibrin; Fibrinogen; Fibrinolysis; Glycosylation; Humans; Hypoglycemic Agents; Insulin; Male; Microscopy, Confocal; Microscopy, Electron, Scanning; Middle Aged; Models, Biological

2008
Effect of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetes.
    Thrombosis research, 1984, Jul-01, Volume: 35, Issue:1

    Topics: Aged; Chlorpropamide; Diabetes Mellitus, Type 2; Endothelium; Female; Fibrinogen; Fibrinolysis; Gliclazide; Humans; Liver; Male; Middle Aged; Muscle, Smooth, Vascular; Plasminogen Activators; Plasminogen Inactivators; Sulfonylurea Compounds

1984
[Longitudinal studies on the prognostic significance of plasma fibrinogen in diabetes mellitus].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1984, Sep-15, Volume: 39, Issue:18

    Topics: Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Prognosis

1984
[Blood viscosity and erythrocyte deformability in diabetic retinopathy].
    La Ricerca in clinica e in laboratorio, 1983, Volume: 13 Suppl 3

    Topics: Adult; Aged; Blood Viscosity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Erythrocytes; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged

1983
[Lipid-metabolic and blood coagulation factors in chronic peripheral arteriopathies].
    Quaderni Sclavo di diagnostica clinica e di laboratorio, 1983, Volume: 19, Issue:1

    Topics: Adult; Aged; Antithrombin III; Arterial Occlusive Diseases; Chronic Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Thrombocytosis

1983
Diastolic dysfunction is not related to changes in glycaemic control over 6 months in type 2 (non-insulin-dependent) diabetes mellitus. A cross-sectional study.
    Acta diabetologica, 1995, Volume: 32, Issue:2

    Topics: Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Diastole; Electrocardiography; Fibrinogen; Follow-Up Studies; Gated Blood-Pool Imaging; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Middle Aged; Reference Values; Systole; Time Factors; Triglycerides; Ventricular Function, Left

1995
Blood coagulation and fibrinolysis in obese NIDDM patients.
    Diabetes research (Edinburgh, Scotland), 1994, Volume: 25, Issue:2

    Topics: Apolipoprotein A-I; Apolipoproteins B; Blood Coagulation; Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Cholesterol, HDL; Diabetes Mellitus; Diabetes Mellitus, Type 2; Factor VII; Female; Fibrinogen; Fibrinolysis; Humans; Insulin; Lipoprotein(a); Male; Middle Aged; Obesity; Plasminogen; Reference Values; Tissue Plasminogen Activator; Triglycerides

1994
Study on alteration of white blood cell deformability of NIDDM patients and the influencing factors.
    Chinese medical journal, 1994, Volume: 107, Issue:12

    Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fibrinogen; Hemorheology; Humans; Leukocytes; Male; Middle Aged

1994
Alteration of oxide reductive and haemostatic factors in type 2 diabetics.
    Journal of internal medicine, 1994, Volume: 236, Issue:5

    Topics: Adult; Blood Coagulation Factors; Diabetes Mellitus, Type 2; Fatty Acids; Fibrinogen; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Phospholipids; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Tissue Plasminogen Activator; von Willebrand Factor

1994
[Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
    Sangre, 1994, Volume: 39, Issue:2

    Topics: Aged; alpha-2-Antiplasmin; Coronary Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Risk Factors; Survivors

1994
Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients.
    Diabetologia, 1993, Volume: 36, Issue:10

    Topics: Adult; Aged; Albuminuria; Biomarkers; Blood Coagulation Factors; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Factor VII; Female; Fibrinogen; Humans; Lipid Peroxides; Male; Middle Aged; Protein C; Protein S; von Willebrand Factor

1993
Decreased plasminogen activator inhibitor-1 activity in newly diagnosed type 2 diabetic patients following dietary modification.
    Diabetic medicine : a journal of the British Diabetic Association, 1993, Volume: 10, Issue:9

    Topics: Biomarkers; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 2; Diet, Diabetic; Factor VII; Factor VIII; Fibrinogen; Glycated Hemoglobin; Humans; Middle Aged; Plasminogen Activator Inhibitor 1; Regression Analysis; Triglycerides

1993
Elevation of factor XIa-alpha 1-antitrypsin complex levels in NIDDM patients with diabetic nephropathy.
    Diabetes, 1993, Volume: 42, Issue:2

    Topics: Albuminuria; alpha 1-Antitrypsin; Antithrombin III; Biomarkers; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Factor XIa; Female; Fibrinogen; Glycated Hemoglobin; Humans; Insulin; Male; Middle Aged; Regression Analysis; Thrombin; Triglycerides

1993
Differences between plasma viscosity and proteins of types 1 and 2 diabetic Africans in early phase of diabetes.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1993, Volume: 25, Issue:1

    Topics: Adult; Aged; Blood Proteins; Blood Viscosity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Middle Aged; Nigeria; Plasma; Serum Albumin; Vascular Diseases

1993
Circadian variations in platelet aggregability in non insulin dependent diabetes patients (NIDDM).
    La Clinica terapeutica, 1993, Volume: 142, Issue:1

    Topics: Aged; Circadian Rhythm; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Insulin; Male; Middle Aged; Platelet Aggregation; Time Factors

1993
Sex differences in coagulation and fibrinolysis in white subjects with non-insulin-dependent diabetes mellitus.
    Arteriosclerosis, thrombosis, and vascular biology, 1996, Volume: 16, Issue:1

    Topics: Aged; Antigens; Blood Coagulation; Body Mass Index; Cholesterol; Diabetes Mellitus, Type 2; Factor VII; Female; Fibrinogen; Fibrinolysis; Glycated Hemoglobin; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Sex Characteristics; Tissue Plasminogen Activator; von Willebrand Factor

1996
Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus.
    Atherosclerosis, 1996, Volume: 120, Issue:1-2

    Topics: Aged; alpha-2-Antiplasmin; Antithrombin III; Blood Coagulation Disorders; Body Mass Index; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Susceptibility; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Japan; Lipoprotein(a); Male; Middle Aged; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Risk Factors; Tissue Plasminogen Activator

1996
Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Multiclinical Study for Diabetic Macroangiopathy (MSDM).
    Diabetes, 1996, Volume: 45 Suppl 3

    Topics: Aged; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Japan; Male; Middle Aged; Regression Analysis; Risk Factors; Triglycerides

1996
Plasma fibrinogen in NIDDM: the Rotterdam study.
    Diabetes care, 1996, Volume: 19, Issue:2

    Topics: Age Factors; Aged; Body Mass Index; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fructosamine; Hexosamines; Humans; Hypertension; Hypoglycemic Agents; Insulin; Male; Middle Aged; Netherlands; Reference Values; Sex Characteristics; Sex Factors; Smoking

1996
Influence of smoking on the survival rate of diabetic patients requiring hemodialysis.
    Diabetes care, 1996, Volume: 19, Issue:6

    Topics: Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prevalence; Renal Dialysis; Retrospective Studies; Risk Assessment; Risk Factors; Smoking; Survival Rate; Time Factors; Triglycerides

1996
Angiopathy affects circulating endothelin-1 levels in type 2 diabetic patients.
    Acta diabetologica, 1995, Volume: 32, Issue:4

    Topics: Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Creatine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelins; Female; Fibrinogen; Humans; Male; Middle Aged; Reference Values; Regression Analysis; Triglycerides; Urea

1995
Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes mellitus.
    Annals of internal medicine, 1996, Oct-15, Volume: 125, Issue:8

    Topics: Adult; Aged; Albuminuria; Arteriosclerosis; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Male; Middle Aged; Regression Analysis; Risk Factors

1996
Plasma fibrinogen and its relationship to plasma sialic acid in non-insulin-dependent diabetes mellitus.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1996, Volume: 7, Issue:6

    Topics: Aged; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Middle Aged; N-Acetylneuraminic Acid

1996
Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM.
    Circulation, 1996, Nov-01, Volume: 94, Issue:9

    Topics: Adult; Diabetes Mellitus, Type 2; Exons; Factor VII; Family Health; Female; Fibrinogen; Genotype; Humans; Insulin Resistance; Male; Middle Aged; Polymorphism, Genetic; Promoter Regions, Genetic; Risk Factors; von Willebrand Factor

1996
Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.
    Acta diabetologica, 1996, Volume: 33, Issue:3

    Topics: Albuminuria; Anticoagulants; Antithrombin III; Blood Coagulation Factors; Blood Pressure; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fibrinogen; Humans; Male; Middle Aged; Peptide Fragments; Protein C; Protein Precursors; Protein S; Prothrombin; Thrombomodulin; Triglycerides

1996
Beta-fibrinogen gene-455 G/A polymorphism and fibrinogen levels. Risk factors for coronary artery disease in subjects with NIDDM.
    Diabetes care, 1996, Volume: 19, Issue:11

    Topics: Adenine; Aged; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Genotype; Guanine; Humans; Hypertension; Male; Middle Aged; Polymorphism, Genetic; Risk Factors

1996
Protein C activation in NIDDM patients.
    Diabetologia, 1996, Volume: 39, Issue:12

    Topics: Adult; Aged; Blood Coagulation; Cohort Studies; Diabetes Mellitus, Type 2; E-Selectin; Enzyme Activation; Female; Fibrinogen; Humans; Male; Middle Aged; Peptide Fragments; Protein C; Protein C Inhibitor; Protein Precursors; Prothrombin; Reference Values; Thrombomodulin

1996
The influence of diabetes on the vasomotor responses of saphenous vein and the development of infra-inguinal vein graft stenosis.
    Diabetes, 1997, Volume: 46, Issue:1

    Topics: Aged; Aged, 80 and over; Amputation, Surgical; Blood Vessel Prosthesis; Bradykinin; Calcimycin; Collagen; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Female; Fibrinogen; Humans; In Vitro Techniques; Indomethacin; Ischemia; Leg; Male; Microscopy, Electron; Middle Aged; NG-Nitroarginine Methyl Ester; Postoperative Complications; Saphenous Vein; Time Factors; Vascular Diseases; Vascular Surgical Procedures; Vasodilation

1997
Effect of bezafibrate on hypercoagulability assessed by fluorogenic prothrombin time in hyperlipidemic patients with non-insulin-dependent diabetes mellitus.
    Thrombosis research, 1997, Jun-15, Volume: 86, Issue:6

    Topics: Aged; Bezafibrate; Blood Coagulation; Body Mass Index; Case-Control Studies; Cholesterol; Diabetes Mellitus, Type 2; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prothrombin Time

1997
Role of leukocytes in diabetic microcirculatory disturbances.
    Microvascular research, 1997, Volume: 54, Issue:1

    Topics: Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinogen; Hematocrit; Hemorheology; Humans; Leukocytes; Membrane Fluidity; Microcirculation; Microscopy, Video; Plasma; Pressure; Reproducibility of Results; Suspensions

1997
Fibrinogen and albuminuria are related to the presence and severity of peripheral arterial disease in women with type 2 diabetes mellitus.
    Angiology, 1997, Volume: 48, Issue:8

    Topics: Aged; Albuminuria; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Lipids; Middle Aged; Peripheral Vascular Diseases; Regression Analysis; Risk Factors

1997
Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients.
    Diabetes care, 1997, Volume: 20, Issue:10

    Topics: Antioxidants; Ascorbic Acid; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Peptide Fragments; Predictive Value of Tests; Protein Precursors; Prothrombin; Reference Values; Regression Analysis; Risk Factors; Thrombosis; Uric Acid; Vitamin A; Vitamin E

1997
Glycaemic control and cardiovascular risk factors in type 2 diabetes: a population-based study.
    Diabetic medicine : a journal of the British Diabetic Association, 1998, Volume: 15, Issue:4

    Topics: Blood Glucose; Cholesterol; Cohort Studies; Diabetes Complications; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Male; Obesity; Risk Factors; Triglycerides

1998
Alterations in erythrocyte aggregability in diabetics: the influence of plasmatic fibrinogen and phospholipids of the red blood cell membrane.
    Clinical hemorheology and microcirculation, 1998, Volume: 18, Issue:4

    Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Erythrocyte Membrane; Female; Fibrinogen; Humans; Male; Middle Aged; Phospholipids

1998
Effect of intensive glycaemic control on fibrinogen plasma concentrations in patients with Type II diabetes mellitus. Relation with beta-fibrinogen genotype.
    Diabetologia, 1998, Volume: 41, Issue:11

    Topics: Blood Glucose; C-Reactive Protein; Deoxyribonuclease HindIII; Diabetes Mellitus, Type 2; Female; Fibrinogen; Genotype; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length

1998
Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).
    Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:3

    Topics: Arteriosclerosis; Asian People; Black People; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysis; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Proinsulin; Regression Analysis; Risk Factors; White People

1999
Enhanced erythrocyte aggregation in type 2 diabetes with late complications.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 1999, Volume: 107, Issue:1

    Topics: Adult; Aged; Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Female; Fibrinogen; Hemorheology; Humans; Male; Middle Aged

1999
Circulating thrombomodulin and hematological alterations in type 2 diabetic patients with retinopathy.
    Journal of atherosclerosis and thrombosis, 1998, Volume: 5, Issue:1

    Topics: Aged; Aged, 80 and over; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antithrombin III; Biomarkers; Blood Glucose; Case-Control Studies; Creatinine; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Endothelium, Vascular; Female; Fibrinogen; Fibrinolysin; Humans; Lipids; Male; Middle Aged; Multivariate Analysis; Peptide Hydrolases; Predictive Value of Tests; Thrombomodulin; Tunica Intima; von Willebrand Factor

1998
Association of plasma fibrinogen level and blood pressure with diabetic retinopathy, and renal complications associated with proliferative diabetic retinopathy, in Type 2 diabetes mellitus.
    Diabetic medicine : a journal of the British Diabetic Association, 1999, Volume: 16, Issue:6

    Topics: Aged; Blood Pressure; Blood Viscosity; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fibrinogen; Humans; Logistic Models; Male; Middle Aged

1999
Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus.
    Acta diabetologica, 1999, Volume: 36, Issue:1-2

    Topics: Adult; Aged; Biomarkers; Blood Glucose; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Interleukin-6; Middle Aged; Receptors, Interleukin-6; Reference Values; Regression Analysis; Triglycerides

1999
Beta-fibrinogen gene G/A-455 polymorphism in relation to fibrinogen concentrations and ischaemic heart disease in Chinese patients with type II diabetes.
    Diabetologia, 1999, Volume: 42, Issue:10

    Topics: Age Factors; Alleles; Body Mass Index; China; Cohort Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Gene Frequency; Genetic Linkage; Genetic Predisposition to Disease; Genotype; Humans; Logistic Models; Male; Middle Aged; Myocardial Ischemia; Polymorphism, Genetic; Risk Factors; Sex Factors; Smoking

1999
Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes.
    Diabetes, 2000, Volume: 49, Issue:1

    Topics: Aged; Aged, 80 and over; Aging; Autoantibodies; Autoantigens; Autoimmunity; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Glutamate Decarboxylase; Humans; Islets of Langerhans; Male; Membrane Proteins; Protein Tyrosine Phosphatases; Receptor-Like Protein Tyrosine Phosphatases, Class 8

2000
Haemostasis and carotid artery wall thickness in non-insulin dependent diabetes mellitus.
    Diabetes research and clinical practice, 2000, Volume: 47, Issue:1

    Topics: Age Distribution; Carotid Arteries; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Prevalence; Prospective Studies; Risk Factors; Sex Distribution

2000
[Diabetes mellitus and fibrinogen. Hemorrheological and microcirculatory consequences].
    Journal des maladies vasculaires, 2000, Volume: 25, Issue:1

    Topics: Adult; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Female; Fibrinogen; Hemorheology; Humans; Male; Microcirculation; Middle Aged

2000
Variations and clinical significance of coagulation and fibrinolysis parameters in patients with diabetes mellitus.
    Journal of Tongji Medical University = Tong ji yi ke da xue xue bao, 1998, Volume: 18, Issue:4

    Topics: Adult; Aged; Antithrombin III; Blood Coagulation; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Thrombophilia

1998
Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
    Diabetes care, 2000, Volume: 23, Issue:1

    Topics: Adult; Blood Glucose; Cholesterol; Cholesterol, HDL; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Insulin; Male; Middle Aged; Nuclear Family; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator; Triglycerides

2000
Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.
    Annals of internal medicine, 2000, Jul-18, Volume: 133, Issue:2

    Topics: Apolipoproteins; Body Constitution; Cholesterol, HDL; Coronary Disease; Diabetes Mellitus, Type 2; Factor VIII; Female; Fibrinogen; Follow-Up Studies; Humans; Incidence; Leukocyte Count; Male; Middle Aged; Prospective Studies; Risk Factors; Serum Albumin; von Willebrand Factor

2000
Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.
    Kidney international, 2000, Volume: 58, Issue:4

    Topics: Albuminuria; Arteriosclerosis; Biomarkers; Blood Pressure; Body Mass Index; C-Reactive Protein; Creatinine; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Humans; Hypertension, Renal; Insulin Resistance; Kidney Failure, Chronic; Male; Middle Aged; Nephritis

2000
Hyperfibrinogenaemia did not improve after treating hyperglycaemia in Chinese type 2 diabetic patients.
    Annals of clinical biochemistry, 2000, Volume: 37 ( Pt 5)

    Topics: Adult; Body Mass Index; China; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Middle Aged; Risk Factors; Statistics as Topic; Triglycerides

2000
Thermographic measurement of skin temperature recovery time of extremities in patients with type 2 diabetes mellitus.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2000, Volume: 108, Issue:7

    Topics: Analysis of Variance; Arteriosclerosis; Blood Pressure; Cold Temperature; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Japan; Male; Middle Aged; Neural Conduction; Plasminogen Activator Inhibitor 1; Reference Values; Regression Analysis; Skin Temperature; Thermography; Time Factors; Toes

2000
Fibrinogen, other cardiovascular risk factors and diabetes mellitus in Hong Kong: a community with high prevalence of Type 2 diabetes mellitus and impaired glucose tolerance.
    Diabetic medicine : a journal of the British Diabetic Association, 2000, Volume: 17, Issue:11

    Topics: Adult; Age Factors; Aged; Asian People; Blood Pressure; Cardiovascular Diseases; Cholesterol, HDL; Confidence Intervals; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Intolerance; Hong Kong; Humans; Hypertension; Male; Middle Aged; Obesity; Prevalence; Risk Factors; Sex Factors; Triglycerides

2000
A global platelet test of thrombosis and thrombolysis detects a prothrombotic state in some patients with non-insulin dependent diabetes and in some patients with stroke.
    Platelets, 2000, Volume: 11, Issue:8

    Topics: Adult; Age Factors; Aged; Antifibrinolytic Agents; Arteriosclerosis; Diabetes Mellitus, Type 2; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Function Tests; Stress, Mechanical; Stroke; Thrombophilia

2000
Carotid intima-media thickness in patients with Type 2 diabetes and hypercholesterolemia.
    Diabetes, nutrition & metabolism, 2001, Volume: 14, Issue:1

    Topics: Age Factors; Arteriosclerosis; Carotid Artery, Common; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hypercholesterolemia; Male; Middle Aged; Risk Factors; Time Factors; Tunica Intima

2001
Relationship between plasma soluble thrombomodulin levels and insulin resistance syndrome in type 2 diabetes: a comparison with von Willebrand factor.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2001, Volume: 109, Issue:4

    Topics: Adult; Aged; Blood Pressure; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diet; Female; Fibrinogen; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Models, Biological; Solubility; Sulfonylurea Compounds; Thrombomodulin; von Willebrand Factor

2001
Insulin resistance as a major determinant of increased coronary heart disease risk in postmenopausal women with Type 2 diabetes mellitus.
    Diabetic medicine : a journal of the British Diabetic Association, 2001, Volume: 18, Issue:6

    Topics: Absorptiometry, Photon; Adipose Tissue; Aged; Albuminuria; Blood Glucose; Blood Pressure; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Electrocardiography; Factor VII; Female; Fibrinogen; Homeostasis; Humans; Insulin; Insulin Resistance; Lipoproteins; Lipoproteins, LDL; Middle Aged; Models, Biological; Plasminogen Activator Inhibitor 1; Postmenopause; Proinsulin; Risk Factors; Triglycerides

2001
Monitoring of cardiovascular risk factors in the diabetic clinics of an Italian region: the MOFRAD study.
    Diabetes, nutrition & metabolism, 2001, Volume: 14, Issue:4

    Topics: Adult; Aged; Ambulatory Care Facilities; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Italy; Lipoproteins, HDL; Male; Middle Aged; Obesity; Risk Factors; Sex Characteristics; Smoking; Triglycerides

2001
Relationship between plasma Endothelin-1 and glycemic control in type 2 diabetes mellitus.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2001, Volume: 33, Issue:12

    Topics: Adult; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Diabetes Mellitus, Type 2; Endothelin-1; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Triglycerides

2001
Impaired hemorheological properties in diabetic patients with lower limb arterial ischaemia.
    Clinical hemorheology and microcirculation, 2001, Volume: 25, Issue:2

    Topics: Adult; Aged; Arteries; Blood Gas Monitoring, Transcutaneous; Blood Viscosity; Case-Control Studies; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Erythrocyte Aggregation; Female; Fibrinogen; Hemorheology; Humans; Hypoxia; Ischemia; Leg; Male; Middle Aged; Serum Albumin

2001
Relationship of abdominal fat with metabolic disorders in diabetes mellitus patients.
    Diabetes research and clinical practice, 2002, Volume: 55, Issue:2

    Topics: Abdomen; Adipose Tissue; Aged; Albuminuria; Antithrombin III; Blood Coagulation Disorders; Blood Pressure; Body Composition; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Fibrinogen; Humans; Insulin; Male; Middle Aged; Peptide Hydrolases; Regression Analysis; Sex Characteristics; Triglycerides; Viscera

2002
Lack of an association of urinary albumin excretion with interleukin-6 or C-reactive protein in patients with type 2 diabetes.
    Acta diabetologica, 2001, Volume: 38, Issue:4

    Topics: Albuminuria; C-Reactive Protein; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Interleukin-6; Male; Middle Aged; Statistics, Nonparametric

2001
Rheological determinants of red blood cell aggregation in diabetic patients in relation to their metabolic control.
    Diabetic medicine : a journal of the British Diabetic Association, 2002, Volume: 19, Issue:2

    Topics: Acute-Phase Proteins; Blood Glucose; Blood Sedimentation; C-Reactive Protein; Cell Adhesion; Cell Aggregation; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Erythrocytes; Female; Fibrinogen; Hemorheology; Humans; In Vitro Techniques; Leukocyte Count; Male; Sensitivity and Specificity; Triglycerides

2002
[Study of platelet membrane glycoproteins and its fibrinogen binding reaction in patients with cerebral infarction and diabetes mellitus].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2000, Volume: 21, Issue:3

    Topics: Adult; Aged; Cerebral Infarction; Diabetes Mellitus, Type 2; Female; Fibrinogen; Flow Cytometry; Humans; Integrin beta3; Male; Middle Aged; P-Selectin; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoprotein IIb; Platelet Membrane Glycoproteins

2000
Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1.
    Metabolism: clinical and experimental, 2002, Volume: 51, Issue:4

    Topics: Administration, Oral; Blood Coagulation; Body Mass Index; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Hypoglycemic Agents; Male; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1; Reference Values; Regression Analysis; Triglycerides

2002
Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
    Diabetes, 2002, Volume: 51, Issue:4

    Topics: Acute-Phase Proteins; Arteriosclerosis; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Ethnicity; Fasting; Female; Fibrinogen; Glucose Tolerance Test; Humans; Hypertension; Incidence; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Regression Analysis; Smoking; United States

2002
Impaired fibrinolysis in premenopausal women and age-matched men with Type 2 diabetes mellitus: a pilot study.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2002, Volume: 50, Issue:2

    Topics: Adult; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysis; Humans; Male; Pilot Projects; Plasminogen Activator Inhibitor 1; Premenopause; Serum Globulins; Sex Characteristics; Tissue Plasminogen Activator

2002
Effect of acupuncture on plasmic levels of insulin, glucagon and hypercoagulability in NIDDM complicated by acute cerebral infarction.
    Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2001, Volume: 21, Issue:4

    Topics: Acupuncture Therapy; Cerebral Infarction; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucagon; Humans; Insulin; Male; Middle Aged; Platelet Aggregation

2001
Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes.
    Diabetes care, 1992, Volume: 15, Issue:10

    Topics: Analysis of Variance; Blood Glucose; Cholesterol; Cholesterol, HDL; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Obesity; Reference Values; Risk Factors; Triglycerides

1992
Hematologic changes in type 2 diabetic patients with various localizations of peripheral vascular disease.
    VASA. Zeitschrift fur Gefasskrankheiten, 1992, Volume: 21, Issue:4

    Topics: Arteriosclerosis Obliterans; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Hematocrit; Hemoglobinometry; Humans; Ischemia; Leg; Leukocyte Count; Male; Middle Aged; Platelet Count

1992
Increased plasminogen activator inhibitor antigen levels in diabetic patients with stable angina.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1991, Volume: 2, Issue:1

    Topics: Adult; Aged; Angina Pectoris; Antithrombin III; Coronary Disease; Diabetes Mellitus, Type 2; Exercise Test; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Peptide Hydrolases; Plasminogen Inactivators; Tissue Plasminogen Activator

1991
Do rheological variables play a role in diabetic peripheral neuropathy?
    Diabetic medicine : a journal of the British Diabetic Association, 1991, Volume: 8, Issue:3

    Topics: Blood Viscosity; Body Mass Index; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Erythrocyte Deformability; Female; Fibrinogen; Glycated Hemoglobin; Hematocrit; Humans; Male; Middle Aged; Reference Values

1991
Activation of coagulation in diabetes mellitus in relation to the presence of vascular complications.
    Diabetic medicine : a journal of the British Diabetic Association, 1991, Volume: 8, Issue:4

    Topics: Adult; Blood Coagulation; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Factor VII; Factor VIIa; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Glycated Hemoglobin; Hemostasis; Humans; Male; Middle Aged; Smoking

1991
Euglobulin fibrinolytic activity in NIDDM patients.
    Diabetes research and clinical practice, 1991, Volume: 13, Issue:3

    Topics: Age Factors; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fibrinogen; Fibrinolysis; Glycated Hemoglobin; Humans; Lipids; Male; Middle Aged; Proteinuria; Reference Values; Regression Analysis; Serum Globulins

1991
Evaluation of red cell deformability by a filtration method in type 1 and type 2 diabetes mellitus with and without vascular complications.
    Diabetes research (Edinburgh, Scotland), 1990, Volume: 13, Issue:2

    Topics: Adult; Aged; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Erythrocyte Deformability; Female; Fibrinogen; Filtration; Glycated Hemoglobin; Hematocrit; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Reference Values; Serum Globulins; Smoking

1990
Hemostatic alterations with exercise conditioning in NIDDM.
    Diabetes care, 1990, Volume: 13, Issue:2

    Topics: Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Fibrinolysis; Fibronectins; Glucose Tolerance Test; Humans; Male; Middle Aged; Physical Exertion; Plasminogen; Tissue Plasminogen Activator

1990
[Tissue-type plasminogen activator and its inhibitor (PAI-1) in plasma in cases of non-insulin-dependent diabetes mellitus (NIDDM)].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1990, Volume: 27, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysis; Humans; Male; Plasminogen Inactivators; Tissue Plasminogen Activator

1990
Plasma fibrinogen levels in type II diabetics.
    Clinical physiology and biochemistry, 1990, Volume: 8, Issue:6

    Topics: Albuminuria; Blood Glucose; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinogen; Glycated Hemoglobin; Humans; Immunoassay; Risk Factors

1990
Haemostatic measures in type 2 diabetic patients with microalbuminuria.
    Diabetic medicine : a journal of the British Diabetic Association, 1990, Volume: 7, Issue:6

    Topics: Aged; Albuminuria; Blood Glucose; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fibrinogen; Fibronectins; Glycated Hemoglobin; Humans; Middle Aged; Reference Values; von Willebrand Factor

1990
Branch retinal vein occlusion: the pathogenetic role of blood viscosity.
    Annals of ophthalmology, 1990, Volume: 22, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Blood Viscosity; Diabetes Mellitus, Type 2; Erythrocyte Deformability; Female; Fibrinogen; Fluorescein Angiography; Fundus Oculi; Hematocrit; Humans; Hypertension; Male; Middle Aged; Retinal Vein Occlusion

1990
Different levels of cardiovascular risk factors in type-2 diabetic patients with lower limb proximal and distal vessel macroangiopathy.
    Cor et vasa, 1990, Volume: 32, Issue:4

    Topics: Apolipoproteins B; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinogen; Humans; Leg; Risk Factors; Ultrasonography

1990
Comparison of plasma viscosity and fibrinogen concentration in African insulin-dependent and non-insulin-dependent diabetics with and without hypertension.
    The West Indian medical journal, 1990, Volume: 39, Issue:3

    Topics: Aged; Blood Viscosity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Random Allocation

1990
Effects of pentoxifylline on proteinuria in normotensive patients with diabetes mellitus.
    DICP : the annals of pharmacotherapy, 1990, Volume: 24, Issue:11

    Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fibrinogen; Humans; Male; Middle Aged; Pentoxifylline; Proteinuria

1990
[Behavior of fibrinogen in diabetic patients in comparison with objective vascular measurements in the ocular fundus].
    Folia haematologica (Leipzig, Germany : 1928), 1985, Volume: 112, Issue:6

    Topics: Adolescent; Adult; Blood Flow Velocity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fibrinogen; Fluorescein Angiography; Humans; Male; Middle Aged; Retinal Vessels

1985
Effects of Chinese medicinal herbs on hemorheology in diabetics.
    Proceedings of the Chinese Academy of Medical Sciences and the Peking Union Medical College = Chung-kuo i hsueh k'o hsueh yuan, Chung-kuo hsieh ho i k'o ta hsueh hsueh pao, 1989, Volume: 4, Issue:3

    Topics: Adult; Blood Viscosity; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Humans; Male; Medicine, Chinese Traditional; Middle Aged; Rheology

1989
PARD: platelet aggregation as a risk factor in diabetics: results of a prospective study.
    Hormone and metabolic research. Supplement series, 1985, Volume: 15

    Topics: Aged; beta-Thromboglobulin; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Factor VIII; Female; Fibrinogen; Glycosuria; Humans; Male; Middle Aged; Platelet Aggregation; Prospective Studies; Reference Values; Risk; Sex Factors

1985
Impaired fibrinolytic response to exercise in type II diabetes: effects of exercise and physical training.
    Metabolism: clinical and experimental, 1988, Volume: 37, Issue:10

    Topics: Adult; Blood Coagulation; Blood Coagulation Tests; Diabetes Mellitus, Type 2; Exercise; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Oxygen Consumption; Physical Education and Training; Prothrombin Time

1988
Diabetic hypertension--the importance of fibrinogen and blood viscosity.
    Journal of human hypertension, 1988, Volume: 2, Issue:2

    Topics: Blood Viscosity; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Sex Factors; Smoking

1988
Haemostasiological parameters as risk factor for new arterial occlusions in diabetics.
    Klinische Wochenschrift, 1986, Oct-15, Volume: 64, Issue:20

    Topics: Aged; Arterial Occlusive Diseases; Blood Coagulation Tests; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; von Willebrand Factor

1986
Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients.
    Pharmatherapeutica, 1987, Volume: 5, Issue:1

    Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Erythrocyte Deformability; Female; Fibrinogen; Humans; Male; Middle Aged; Pentoxifylline; Theobromine

1987
Fibrinogen interaction with platelets of diabetic subjects.
    Thrombosis research, 1987, May-01, Volume: 46, Issue:3

    Topics: Adenosine Diphosphate; Adult; Aged; Alprostadil; Antibodies, Monoclonal; Binding Sites; Blood Platelets; Chymotrypsin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Membrane Glycoproteins; Reference Values

1987
Plasma fibrinogen in a diabetic population.
    The Journal of the Royal College of General Practitioners, 1986, Volume: 36, Issue:285

    Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male

1986
The effects of oral stanozolol on fibrinolysis in type 2 diabetes mellitus.
    Thrombosis research, 1986, Oct-15, Volume: 44, Issue:2

    Topics: Administration, Oral; Adult; Aged; alpha-2-Antiplasmin; Diabetes Mellitus, Type 2; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Plasminogen; Research Design; Stanozolol

1986
[Hemorheologic studies for evaluating microcirculation in patients with peripheral arterial circulatory disorders and diabetes mellitus].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1986, Oct-01, Volume: 41, Issue:19

    Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Viscosity; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Erythrocyte Aggregation; Erythrocyte Deformability; Fibrinogen; Hematocrit; Humans; Ischemia; Leg; Male; Microcirculation; Middle Aged; Rheology

1986
Fibrinopeptide-A in diabetes mellitus. Relation to levels of blood glucose, fibrinogen disappearance, and hemodynamic changes.
    Diabetes, 1985, Volume: 34, Issue:9

    Topics: Adolescent; Adult; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Fibrinopeptide A; Glucose; Hemodynamics; Humans; Male; Middle Aged

1985
Diabetic retinal vascular complications and erythrocyte filtrability; results of a 2-year follow-up study with pentoxifylline.
    Pharmatherapeutica, 1985, Volume: 4, Issue:6

    Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Erythrocyte Deformability; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Middle Aged; Pentoxifylline; Proteinuria; Theobromine; Time Factors

1985
[Biochemical aspects of the pathogenesis of the late diabetic syndrome].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1985, Oct-15, Volume: 40, Issue:20

    Topics: Apoproteins; Blood Glucose; Collagen; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Fibrinogen; Glycated Hemoglobin; Humans; Membrane Proteins; Myelin Proteins; Serum Albumin

1985